EXPLORE THE SCIENTIFIC PROGRAMME #EADVCONGRESS

COMING NEXT:

COVID-19 Articles

EADV is closely monitoring the ongoing coronavirus pandemic. As the situation continues to change rapidly, our top priority remains the health, safety, and well-being of our community.

We will continue to share knowledge and information through our channels.

General

Pitfalls of possible reporting of same patients with COVID-19 in various dermatology journals Kluger N. J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16690SARS-CoV, Mers-CoV and Covid-19: : what differences from a dermatological viewpoint? Rongioletti F. J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16738Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic Chernyshov PV, Tomas-Aragones L, Augustin M, Svensson A, Bewley A, Poot F, Szepietowski JC, Marron SE, Manolache L, Pustisek N, Suru A, Salavastru CM, Blome C, Salek MS, Abeni D, Sampogna F, Dalgard F, Linder D, Ewers A, Finlay AY. J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16720Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R. J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16953.Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A. J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16956SARS-CoV-2 spike protein in a chilblain-like skin lesion is present in both endothelial and eccrine cells T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres‐Reyes, R. Schlottmann, W.E. Schmidt, R. Hayajneh, A. Sriram, J.C. Becker J Eur Acad Dermatol Venereol. 2020 Sep 25. doi.org/10.1111/jdv.16970

Cross-country comparisons of Google searches for chilblains before and during the COVID-19 pandemic

Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection A Barrera-Godínez, S Méndez-Flores, M Gatica-Torres, A Rosales-Sotomayor, KI Campos-Jiménez, DM Carrillo-Córdova, MC Durand-Muñoz, GL Mena-Hernández, YK Melchor-Mendoza, AL Ruelas-Villavicencio, A García-Irigoyen, GA Acatitla-Acevedo, S Toussaint-Caire, J Domínguez-Cherit J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17381SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations B Cribier, C Taieb, M Saint Aroman, J Shourick J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17380Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study SK Mahil, M Yates, ZZN Yiu, SM Langan, T Tsakok, N Dand, KJ Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, H Bachelez, F Capon, CR Contreras, C De La Cruz, P Di Meglio, P Gisondi, D Jullien, J Lambert, L Naldi, S Norton, L Puig, P Spuls, T Torres, RB Warren, H Waweru, J Weinman, MA Brown, JB Galloway, CM Griffiths, JN Barker, CH Smith, On behalf of the PsoProtect study group J Eur Acad Dermatol Venereol. 2021 Jun 17 com/doi/10.1111/jdv.17450Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak E.J. Chun, J.K. Kim, S.Y. Yang, S.S. Kim, C.W. Kim J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17640Estimating the incidence of Cutaneous COVID-19 reactions on the general population in a territorial setting C. Zengarini, A. Guglielmo, M. Giovani, C. Preci, E. Dika, B.M. Piraccini, A. Pileri J Eur Acad Dermatol Venereol. 2022 Jan 26 doi.org/10.1111/jdv.17970Prevalence and patterns of cutaneous manifestations in 1245 COVID-19 patients in Japan: a single-centre study T. Sugai, Y. Fujita, E. Inamura, Y. Maya, S. Shimizu J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18062Ultrastructural evidence for anagen hair follicle infection with SARS-CoV-2 in early-onset COVID-19 effluvium I.F.S. Mazeto,C.C. Brommonschenkel,A.C. Miola,P. Müller Ramos,D. Carvalho dos Santos,H.A. Miot J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16690A spectrum of leprosy reactions triggered by Covid-19 vaccination: a series of four casesN. Saraswat,D. M. Tripathy,S. Kumar,P. Awasthi,M. M. Gopal J Eur Acad Dermatol Venereol. 2022 June 29 doi.org/10.1111/jdv.16738Reply to ‘Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study’. by Bawane J et alL. Potestio,L. Genco,A. Villani,C. Marasca,G. Fabbrocini,L. Fornaro,A. Ruggiero,F. Martora J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16720Face mask-induced purpura: another unexpected effect of COVID eraV. Piccolo,A. Bassi,C. Mazzatenta,T. Russo,G. Argenziano,M. Cutrone,Markus ES Danielsson Darlington,R. Grimalt J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18392Effects of COVID-19 pandemic on malignant melanoma diagnosisAlessia Villani,Massimiliano Scalvenzi,Gabriella Fabbrocini,Luigi Fornaro,Gianluca Guerrasio,Luca Potestio J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18545Despite the use of ivermectin during the COVID pandemic, scabies keeps playing tricks with usJuliana Polizel Ocanha-Xavier,José Cândido Caldeira Xavier-Junior J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18547

Cutaneous manifestations of COVID-19

Cutaneous manifestations in COVID‐19: a first perspective

Recalcati, S.

J Eur Acad Dermatol Venereol. 2020 Mar 26. doi: 10.1111/jdv.16387

Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies

Fernandez-Nieto D, Ortega-Quijano D, Segurado-Miravalles G, Pindado-Ortega C, Prieto-Barrios M, Jimenez-Cauhe J.

J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16470

Comment on “Cutaneous manifestations in COVID-19: a first perspective ” by Recalcati S.

Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson Regnault M.

J Eur Acad Dermatol Venereol. 2020 Apr 21. doi: 10.1111/jdv.16519

Cutaneous manifestations in COVID-19: a new contribution

Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD

J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16474

COVID-19 and cutaneous manifestations

Mungmungpuntipantip R, Wiwanitkit V.

J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16483

A distinctive skin rash associated with Coronavirus Disease 2019?

Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L.

J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16471

Urticarial eruption in COVID-19 infection

Henry D, Ackerman M, Sancelme E, Finon A, Esteve E.

J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16472

Viral exanthem in COVID-19, a clinical enigma with biological significance

Su CJ, Lee CH.

J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16469

Cutaneous manifestation of COVID-19 in images: A case report

Avellana Moreno R, Villa E, Avellana Moreno V, Estela Villa C, Aparicio M, Fontanella A.

J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16531

Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome

Tammaro A, Adebanjo GAR, Parisella FR, Pezzuto A, Rello J.

J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16530

Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection

van Damme C, Berlingin E, Saussez S, Accaputo O.

J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16523

Did Whatsapp® reveal a new cutaneous COVID-19 manifestation?

Duong TA, Velter C, Rybojad M, Comte C, Bagot M, Sulimovic L, Bouaziz JD.

J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16534

Acral cutaneous lesions in the time of COVID-19

Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, Dainese E, Vanzati A, Fantini F.

J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16533

SARS-CoV-2 infection presenting as a febrile rash

Amatore F, Macagno N, Mailhe M, Demarez B, Gaudy-Marqueste C, Grob JJ, Raoult D, Brouqui P, Richard MA.

J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16528

Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients

Piccolo V, Neri I, Filippeschi C, Oranges T, Argenziano G, Battarra VC, Berti S, Manunza F, Belloni Fortina A, Di Lernia V, Boccaletti V, De Bernardis G, Brunetti B, Mazzatenta C, Bassi A.

J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16526

Symmetric cutaneous vasculitis in COVID-19 pneumonia

Castelnovo L, Capelli F, Tamburello A, Maria Faggioli P, Mazzone A.

J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16589

Vascular skin symptoms in COVID-19: a french observational study

Bouaziz JD, Duong T, Jachiet M, Velter C, Lestang P, Cassius C, Arsouze A, Domergue Than Trong E, Bagot M, Begon E, Sulimovic L, Rybojad M.

J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16544

Histological pattern in Covid-19 induced viral rash

Zengarini C, Orioni G, Cascavilla A, Horna Solera C, Fulgaro C, Misciali C, Patrizi A, Gaspari V.

J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16569

Acro-ischemia in hospitalized COVID-19 patients

Suarez-Valle A, Fernandez-Nieto D, Diaz-Guimaraens B, Dominguez-Santas M, Carretero I, Perez-Garcia B.

J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16592

Pityriasis rosea as a cutaneous manifestation of COVID-19 infection

Ehsani AH, Nasimi M, Bigdelo Z.

J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16579

The use of Google trends for acral symptoms during COVID-19 outbreak in France

Kluger N, Scrivener Y.

J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16572

Drug-induced vasculitis in a patient with COVID-19

Ramirez AV, Efe D, Fischer M.

J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16588

A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect?

Skroza N, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Michelini S, Tolino E, Proietti I, Di Cristofano C, Petrozza V, Potenza C.

J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16633

Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2

Janah H, Zinebi A, Elbenaye J.

J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16623

Urticarial eruption in Coronavirus Disease 2019 (COVID-19) infection: a case report in Tangerang, Indonesia

Gunawan C, Angela, Widysanto A.

J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16622

A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema

Herrero-Moyano M, Capusan TM, Andreu-Barasoain M, Alcántara-González J, Ruano-Del Salado M, Sánchez-Largo Uceda ME, Calzado-Villarreal L, Pérez-González Y.

J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16631

Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman

Robustelli Test E, Vezzoli P, Carugno A, Raponi F, Gianatti A, Rongioletti F, Sena P.

J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16613

Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection”: Urticaria-like lesions in COVID-19 patients are not really urticaria. A case with clinicopathologic correlation

Rodríguez-Jiménez P, Chicharro P, De Argila D, Muñoz-Hernández P, Llamas-Velasco M.

J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16618

Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient

Locatelli AG, Robustelli Test E, Vezzoli P, Carugno A, Moggio E, Consonni L, Gianatti A, Sena P.

J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16617

Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?

Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S.

J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16636

Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?

Goldust M, Abdelmaksoud A, Shuang Z, Xiang C, Navarini AA.

J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16639

Chilblain acral lesions in the COVID -19 era. Are they marker of infection in asymptomatic patients?

Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S.

J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.166636

Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report

Mayor-Ibarguren A, Feito-Rodriguez M, Quintana Castanedo L, Ruiz-Bravo E, Montero Vega D, Herranz-Pinto P.

J Eur Acad Dermatol Venereol. 2020 May 22 doi: 10.1111/jdv.16670

A case of cefditoren‐induced Acute Generalized Exanthematous Pustulosis during COVID‐19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue

I. Torres‐Navarro, C. Abril‐Pérez, J. Roca‐Ginés, J. Sánchez‐Arráez, R. Botella‐Estrada

J Eur Acad Dermatol Venereol. 2020 May 26;10.1111/jdv.16664. doi: 10.1111/jdv.16664

Iatrogenic dermatitis in times of COVID-19: A pandemic within a pandemic

Bhatia R, Sindhuja T, Bhatia S, Dev T, Gupta A, Bajpai M, Gupta S.

J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16710

Urticaria (angioedema) and COVID- 19 infection

Najafzadeh M, Shahzad F, Ghaderi N, Ansari K, Jacob B, Wright A.

J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16721. [Epub ahead of print]. Case report

No antibody response in acral cutaneous manifestations associated with COVID-19?

Mahieu R, Tillard L, Le Guillou-Guillemette H, Vinatier E, Jeannin P, Croué A, Le Corre Y, Vandamme YM.

J Eur Acad Dermatol Venereol. 2020 Jun 2. doi: 10.1111/jdv.16688

Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic

García-Gil MF, García García M, Monte Serrano J, Prieto-Torres L, Ara-Martín M.

J Eur Acad Dermatol Venereol. 2020 May 20. doi: 10.1111/jdv.16644

Diversity of clinical appearance of cutaneous manifestations in the course of COVID‐19

Guarneri C, Venanzi Rullo E, Gallizzi R, Ceccarelli M, Cannavò SP, Nunnari G.

J Eur Acad Dermatol Venereol. 2020 May 22. doi: 10.1111/jdv.16669

Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19)

Dominguez-Santas M, Diaz-Guimaraens B, Garcia Abellas P, Moreno-Garcia Del Real C, Burgos-Blasco P, Suarez-Valle A.

J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16663

Late onset of acral necrosis after SARS-CoV-2 infection resolution

Balestri R, Termine S, Rech G, Girardelli CR.

J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16668

COVID-19 Presenting with Atypical Sweet’s Syndrome

Taşkın B, Vural S, Altuğ E, Demirkesen C, Kocatürk E, Çelebi İ, Ferhanoğlu B, Alper S.

J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16662

Acro-ischemia and COVID-19 infection: clinical and histopathological features

Calvão J, Relvas M, Pinho A, Brinca A, Cardoso JC.

J Eur Acad Dermatol Venereol. 2020 Jun 2. doi: 10.1111/jdv.16687

COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy

Gaspari V, Neri I, Misciali C, Patrizi A.

J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16693

The red half moon nail sign: a novel manifestation of Coronavirus infection

Neri I, Guglielmo A, Virdi A, Gaspari V, Starace M, Piraccini BM.

J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16747

Erythema multiforme and Kawasaki disease associated with COVID‐19 infection in children

Labé P, Ly A, Sin C, Nasser M, Chapelon-Fromont E, Ben Saïd P, Mahé E.

J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16666

Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?

Rosell-Díaz AM, Mateos-Mayo A, Nieto-Benito LM, Balaguer-Franch I, Hernández de E, la Torre-Ruiz, Laínez-Nuez A, Suárez-Fernández R, Bergón-Sendín M.

J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16709

Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection

Annunziata MC, Patrì A, Ruggiero A, Di Guida A, Menicanti C, Greco V, Fabbrocini G.

J Eur Acad Dermatol Venereol. 2020 Jun 18. doi: 10.1111/jdv.16769

The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases

Rubio-Muniz CA, Puerta-Peña M, Falkenhain-López D, Arroyo-Andrés J, Agud-Dios M, Rodriguez-Peralto JL, Ortiz-Romero PL, Rivera-Díaz R.

J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16734

Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not “varicella-like”

Mahé A, Birckel E, Merklen C, Lefèbvre P, Hannedouche C, Jost M, Droy-Dupré L.

J Eur Acad Dermatol Venereol. 2020 Jun 5. doi: 10.1111/jdv.16706

Covid-19 and outbreak of chilblains: are they related?

Lesort C, Kanitakis J, Villani A, Ducroux E, Bouschon P, Fattouh K, Bensaid B, Danset M, Jullien D.

J Eur Acad Dermatol Venereol. 2020 Jun 27. doi: 10.1111/jdv.16779

Eosinophilic granulomatosis with polyangiitis mimicking COVID-19: a case report

Hashizume H, Sano Y, Furukawa S, Imokawa S.

J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16705

Retiform purpura as a dermatological sign of COVID-19 coagulopathy

Bosch-Amate X, Giavedoni P, Podlipnik S, Andreu-Febrer C, Sanz-Beltran J, Garcia-Herrera A, Alós L, Mascaró JM Jr.

J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16689

COVID-19 Lockdown induced acral dermatosis in children

Bodak N, Chiaverini C, Barbarot S.

J Eur Acad Dermatol Venereol. 2020 Jun 28. doi: 10.1111/jdv.16797

A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection

El Hachem M, Diociaiuti A, Concato C, Carsetti R, Carnevale C, Ciofi Degli Atti M, Giovannelli L, Latella E, Porzio O, Rossi S, Stracuzzi A, Zaffina S, Onetti Muda A, Zambruno G, Alaggio R.

J Eur Acad Dermatol Venereol. 2020 May 31. doi: 10.1111/jdv.16682

Histological findings in chilblain lupus-like COVID lesions: in search of an answer to understand their aetiology

Rodríguez-Villa Lario A, Vega-Díez D, González-Cañete M, Gómez-Zubiaur A, Pérez-Mesonero R, Bandini M, Polo-Rodríguez I, Vélez-Velázquez D, Trasobares-Marugán L.

J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16733

Major cluster of paediatric ‘true’ primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown

Iria N, Annalucia V, Ilaria C, Alba G, Tiziana L, Liliana G, Cosimo M, Annalisa P, Marcello L.

J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16751

An unusual case of bullous hemorrhagic vasculitis in a COVID-19 patient

Negrini S, Guadagno A, Greco M, Parodi A, Burlando M.

J Eur Acad Dermatol Venereol. 2020 Jun 19. doi: 10.1111/jdv.16760

COVID-19 and cutaneous manifestations: A systematic review

Zhao Q, Fang X, Pang Z, Zhang B, Liu H, Zhang F.

J Eur Acad Dermatol Venereol. 2020 Jun 28. doi: 10.1111/jdv.16778

Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization

Bitar C, Chan MP, Harms PW, Fullen DR, Gudjonsson JE, Eshaq M, Renati S, Nikle AB, Allen A, Hawkins SD, Huerta T, Lowe L, Andea AA.

J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16741

Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description

Larrondo J, Cabrera R, Gosch M, Larrondo F, Aylwin M, Castro A.

J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16732

Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?

de Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, Selda-Enriquez G, Carretero I, Moreno C, Fernández-Guarino M.

J Eur Acad Dermatol Venereol. 2020 Jun 8. doi: 10.1111/jdv.16713

A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19

Caputo V, Schroeder J, Rongioletti F.

J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16737

Cutaneous autoimmune diseases during COVID 19 pandemic

Günther C, Aschoff R, Beissert S

J Eur Acad Dermatol Venereol. 2020 Jun 13.doi.org/10.1111/jdv.16753

Relapsing symmetric livedo reticularis in a patient with COVID‐19 infection

Verheyden M, Grosber M, Gutermuth J, Velkeniers B.

J Eur Acad Dermatol Venereol. 2020 Jun 25. doi: 10.1111/jdv.16773

Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients

Reymundo A, Fernáldez-Bernáldez A, Reolid A, Butrón B, Fernández-Rico P, Muñoz-Hernández P, De Argila D, Llamas-Velasco M.

J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16707

Cutaneous manifestations of SARS-CoV-2 infection: a clinical update

Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L.

J Eur Acad Dermatol Venereol. 2020 Jun 25. doi: 10.1111/jdv.16774

Falkenhain-López D, Agud-Dios M, Ortiz-Romero PL, Sánchez-Velázquez A.

J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16740

SARS-CoV-2, skin lesions and the need of a multidisciplinary approach

Cabrera-Hernández R, Solano-Solares E, Chica-Guzmán V, Fernández-Guarino M, Fernández-Nieto D, Ortega-Quijano D, de-Andrés-Martín A, Moreno C, Carretero-Barrio I, García-Abellás P, González-de-Olano D, de-la-Hoz-Caballer B.

J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16745

Introductory histopathologic findings may shed light on COVID19 pediatric hyperinflammatory shock syndrome

Schnapp A, Abulhija H, Maly A, Armoni-Weiss G, Levin Y, Faitatziadou SM, Molho-Pessach V.

J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16749

Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy

Del Giudice P, Boudoumi D, Le Guen B, Reverte M, Gutnecht J, Lacour JP, Kraemer JP, Motard A, Roa M.

J Eur Acad Dermatol Venereol. 2020 Jun 18. doi: 10.1111/jdv.16763

Two cases of cutaneous eruptions due to COVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology

Ho BWY, Wang D, Tan LYC, Bundele MM, Tan CH, Lim JH.

J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16736

Concurrent chilblains and retinal vasculitis in a child with COVID-19

Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R.

J Eur Acad Dermatol Venereol. 2020 Jul 2. doi: 10.1111/jdv.16801

Acute acral cutaneous manifestations during the COVID-19 pandemic: a single center experience

García-Legaz Martínez M, Martínez-Doménech Á, Magdaleno-Tapial J, Valenzuela-Oñate C, Partarrieu-Mejías F, Lorca-Spröhnle J, Casanova-Esquembre A, Pérez-Ferriols A, Alegre-de Miquel V.

J Eur Acad Dermatol Venereol. 2020 Jun 26. doi: 10.1111/jdv.16777

Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection

Rouanet J, Lang E, Beltzung F, Evrard B, Henquell C, Joulie I, D’Incan M.

J Eur Acad Dermatol Venereol. 2020 Jun 26. doi: 10.1111/jdv.16776

Dermoscopy features of COVID-19-related chilblains in children and adolescents

Navarro L, Andina D, Noguera-Morel L, Hernández-Martín A, Colmenero I, Torrelo A.

J Eur Acad Dermatol Venereol. 2020 Jul 2. doi: 10.1111/jdv.16800

Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature

Matar S, Oulès B, Sohier P, Chosidow O, Beylot-Barry M, Dupin N, Aractingi S.

J Eur Acad Dermatol Venereol. 2020 Jun 26. doi: 10.1111/jdv.16775

Hayakawa J, Takakura H, Mizukawa Y, Shiohara T.

J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16878

Acral skin eruption observed during SARS-CoV-2 pandemic: red palms and soles

Neri I, Patrizi A, Gabrielli L, Virdi A, Veronesi G, Corsini I, Lazzarotto T, Lanari M, Misciali C, Guglielmo A.

J Eur Acad Dermatol Venereol. 2020 Aug 20. doi: 10.1111/jdv.16881

Generalized Pustular Figurate Erythema. First Report in Two COVID-19 Patients on Hydroxychloroquine

Abadías-Granado I, Palma-Ruiz AM, Cerro PA, Morales-Callaghan AM, Gómez-Mateo MC, Gilaberte Y, Schwartz RA.

J Eur Acad Dermatol Venereol. 2020 Sep 1. doi: 10.1111/jdv.16903

Skin manifestations in COVID-19 provide a clue for disease’s pathophysiology understanding

Kubanov AA, Deryabin DG.

J Eur Acad Dermatol Venereol. 2020 Sep 1. doi: 10.1111/jdv.16902

A potential new trigger for aquagenic wrinkling of the palms caused by COVID-19 outbreak

Tai Y, Fukumoto T, Oka M, Nishigori C.

J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16906

Chilblains and COVID-19: further evidence against a causal association

M. Baeck, C. Peeters, A. Herman

J Eur Acad Dermatol Venereol. 2020 Aug 31. doi.org/10.1111/jdv.16901

Cutaneous Symptoms of Patients Diagnosed with Covid-19 in One Province: A Cross-Sectional Survey

Öksüm Solak E, Baran Ketencioglu B, Aslaner H, Çinar SL, Kartal D, Benli AR, Borlu M.

J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16904

Self-reported cutaneous manifestations in 1,429 Brazilian COVID-19 patients

Miot HA, Ianhez M, Ramos PM.

J Eur Acad Dermatol Venereol. 2020 Nov 2. doi: 10.1111/jdv.17024

Why are chilblains underreported in Nordic countries during the COVID-19 pandemic? An analysis of Google trends

Kluger N.

J Eur Acad Dermatol Venereol. 2020 Oct 3 doi.org/10.1111/jdv.16974

SARS-CoV-2-induced telogen effluvium: a multicentric study

O.M. Moreno‐Arrones A. Lobato‐Berezo A. Gomez‐Zubiaur S. Arias‐Santiago D. Saceda‐Corralo C. Bernardez‐Guerra R. Grimalt P. Fernandez‐Crehuet J. Ferrando R. Gil A. Hermosa‐Gelbard R. Rodrigues‐Barata D. Fernandez‐Nieto S. Merlos‐Navarro S. Vañó‐Galván

J Eur Acad Dermatol Venereol. 2020 Nov 21 doi.org/10.1111/jdv.17045

Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant. A cross-sectional study

D. Fernandez‐Nieto D. Ortega‐Quijano A. Suarez‐Valle J. Jimenez‐Cauhe P. Jaen‐Olasolo M. Fernandez‐Guarino

J Eur Acad Dermatol Venereol. 2020 Dec 1 doi.org/10.1111/jdv.17051

Palmoplantar erythrodysesthesia: a diagnostic sign of COVID‐19

A. Nuno‐Gonzalez K. Magaletsky M. Feito Rodríguez A. Mayor Ibarguren M.J. Beato E. Ruiz Bravo P. Herranz Pinto

J Eur Acad Dermatol Venereol. 2020 Dec 8 doi.org/10.1111/jdv.17074

Pityriasis rosea as a leading manifestation of COVID-19 infection

R. Merhy, A.S. Sarkis, F. Stephan

J Eur Acad Dermatol Venereol. 2020 Nov 30 doi.org/10.1111/jdv.17052

Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR

M. F. García‐Gil J. Monte‐Serrano M. García García L. Prieto‐Torres A. J. Pascual‐del‐Riquelme I. Casas Flecha M. Ara‐Martín

J Eur Acad Dermatol Venereol. 2021 Feb 4 doi.org/10.1111/jdv.17146

Chilblain-like lesions and COVID-19: second wave, second outbreak

V. Piccolo A. Bassi T. Russo C. Mazzatenta M. Baraldi G. Argenziano I. Neri M. Cutrone

J Eur Acad Dermatol Venereol. 2021 Feb 5 doi.org/10.1111/jdv.17145

Relapse of chilblain-like lesions during the second wave of COVID-19

S. Recalcati T. Barbagallo S. Tonolo M. Milani F. Fantini

J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17168

Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late onset skin manifestation in previously infected individuals

I. Neri F. Conti A. Virdi A. Guglielmo L. Leonardi I. Corsini C. Ghizzi L. Gabrielli T. Lazzarotto M. Lanari A. Patrizi C. Misciali

J Eur Acad Dermatol Venereol. 2021 Mar 2 doi.org/10.1111/jdv.17194

Association Between COVID-19 and Chilblains: A Case-Control Study

D. Ortega‐Quijano D. Fernandez‐Nieto J. Jimenez‐Cauhe J.L. Cortes‐Cuevas D. Marcos‐Mencia M. Rodriguez‐Dominguez G. Segurado‐Miravalles M. Fernandez‐Guarino P. Jaen‐Olasolo

J Eur Acad Dermatol Venereol. 2021 Mar 2 doi.org/10.1111/jdv.17195

Follow-up of dermatological manifestations in non-critical hospitalized patients with COVID-19 pneumonia and their prognostic correlation with disease severity

A. García‐Irigoyen G.A. Acatitla‐Acevedo A. Barrera‐Godínez S. Méndez‐Flores J. Domínguez‐Cherit

J Eur Acad Dermatol Venereol. 2021 Mar 17 doi.org/10.1111/jdv.17236

Periocular capillaritis in a COVID-19 positive patient: report of a case

A. Paganelli F. Garbarino L. Bigi

J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17227

Under-representation of people of African ancestry in publications on the cutaneous manifestations of COVID-19: coincidence or physiology?

C Cassius L Frumholtz A de Masson O Dadzie A Petit Saint‐Louis CORE (COvid Research) group

J Eur Acad Dermatol Venereol. 2021 Apr 18 doi.org/10.1111/jdv.17289

Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2?

S Signa AR Sementa MC Coccia C Pastorino G Viglizzo S Viola S Volpi C Occella D Bleidl M Acquila E Castagnola A Ravelli F Manunza

J Eur Acad Dermatol Venereol. 2021 Apr 19 doi.org/10.1111/jdv.17283

Covid-19-triggered sarcoidal granulomas mimicking scar sarcoidosis

A Polat Ekinci N Büyükbabani S Meşe G Pehlivan NG Okumuş A Ağaçfidan E Özkaya

J Eur Acad Dermatol Venereol. 2021 Apr 19 doi.org/10.1111/jdv.17286

Acute postinfectious Pityriasis Rubra Pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features

D. Kadylak, W. Barańska-Rybak

J Eur Acad Dermatol Venereol. 2021 May 31 oi/full/10.1111/jdv.17424

Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology

R. Guelimi, R. Salle, L. Dousset, H. Assier, S. Fourati, Z. Bhujoo, S. Barbarot, C. Boulard, C. Cazanave, A. Colin, E. Kostrzewa, C. Lesort, A. Levy Roy, F. Lombart, J. Marco Bonnet, L. Marty, J.B. Monfort, L. Riffaud, M. Samimi, M. Tardieu, E. Sbidian, P. Wolkenstein, L. Le Cleach, M. Beylot-Barry

J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17322

Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19

Betul Demir, Esma Inan Yuksel, Demet Cicek, Sedatcan Turkoglu

J Eur Acad Dermatol Venereol. 2021 May 13 doi/abs/10.1111/jdv.17347

Recurrent injection-site reactions after incorrect subcutaneous administration of the BNT162b2 vaccine against SARS-CoV-2

M. Gyldenløve, L. Skov, C.B. Hansen, P. Garred

J Eur Acad Dermatol Venereol. 2021 May 12 oi/full/10.1111/jdv.17341

Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic

Parna Moghadam, Laure Frumholtz, Léa Jaume, Adèle De Masson, Marie Jachiet, Edouard Begon, Luc Sulimovic, Antoine Petit, Hervé Bachelez, Martine Bagot, Jean-David Bouaziz, Charles Cassius, Saint-Louis CORE (COvid REsearch)

J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17393

Urticarial Vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg?

Paulo Ricardo Criado, Roberta Fachini Jardim Criado, Raffaele Gianotti, Beatrice Artinez Zugaib Abdalla, Thais Prota Hussein Pincelli, Alexandre Osores Michalany, Nilceo Schwery Michalany

J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17391

Development of eruptive pseudoangiomatosis following COVID-19 immunization – Apropos of 5 cases

A. Mohta, S. K. Jain, R. D. Mehta, A. Arora

J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17499

Cutaneous manifestations of patients hospitalized with coronavirus disease 2019 (COVID-19)

P Ramezani Darmian, Z Memarzadeh, R Aryan, Y Nahidi, Z Mehri, A taghipour, N Samimi, M Amini, P Layegh

J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17557

Retiform purpura and extensive skin necrosis as the single manifestation of SARS-CoV-2 infection

M. Brito Caldeira, M. Pestana, A.L. João, C. Fernandes, A. João, N. Cunha

J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17562

Are the chilblain-like lesions observed during the COVID-19 pandemic due to SARS-CoV-2? Systematic review and meta-analysis

V. Sánchez-García,R. Hernández-Quiles,E. de-Miguel-Balsa,A. Docampo-Simón,I. Belinchón-Romero,J.M. Ramos-Rincón

J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17672

SARS-CoV-2 in the sweat of COVID-19-positive patients: a possible route of transmission?

S. Recalcati,S. Tonolo,E. Meroni,F. Fantini

J Eur Acad Dermatol Venereol. 2021 Aug 20 oi/full/10.1111/jdv.17607

Erythema annulare centrifugum triggered by SARS-CoV-2 infection

N. Setó-Torrent,A. Altemir,M. Iglesias-Sancho,M.T. Fernández-Figueras

J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17645

Non-invasive instrumental examinations of cutaneous, adnexal and mucosal manifestations after SARS-COV-2 infection in adult and children

I. Proietti,E. Tolino,A. Mambrin,N. Skroza,N. Bernardini,A. Marchesiello,F. Marraffa,S. Michelini,G. Rossi,S. Volpe,E. Del Giudice,R. Lubrano,C. Potenza

J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17805

Is there a POST-COVID dermatological syndrome? The integrated dermato-infectious disease experience of a single center

F. Diotallevi, S. Mazzanti, P. Properzi, S. Olivieri, A. Giacometti ,A. Offidani

J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17803

COVID-19 cutaneous manifestations in pediatric patients: 24 MIS-C and 6 Kawasaki disease cases

A. Tammaro, D. Karim, G.A.R. Adebanjo, F.R. Parisella, C. Chello, A.F. Salih, J. Rello

J Eur Acad Dermatol Venereol. 2021 Nov 22 doi.org/10.1111/jdv.17828

Pityrosporum folliculitis in critically ill COVID-19 patients

F.L.X. Peres,R.R. Bonamigo,G.B. Bottega,F.L. Staub,A.S. Cartell,R.M. Bakos

J Eur Acad Dermatol Venereol. 2021 Nov 27 doi.org/10.1111/jdv.17842

Multisystem inflammatory syndrome in adults (MIS-A): a new addition to Covid-19 puzzle

K. Hajra,U. Chakraborty,K. Chatterjee,A. Chandra,S. Halder

J Eur Acad Dermatol Venereol. 2021 Nov 27 doi.org/10.1111/jdv.17841

Eruptive pyogenic granulomas following COVID-19

C.A. Maronese, C. Moltrasio, D.A. Marletta, G. Genovese, A.V. Marzano

J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17953

Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthema

A. Sechi, A. Bassi, C. Mazzatenta, M. Cutrone, L. Naldi, G. Argenziano, V. Piccolo

J Eur Acad Dermatol Venereol. 2022 Mar 19 doi.org/10.1111/jdv.18093

Autoimmune bullous dermatoses associated with COVID-19 outbreak in Russian patients: a single case series

A. Lepekhova, E. Grekova, O. Olisova, E. Dunaeva,S. Ali, I. Maximov, N. Teplyuk

J Eur Acad Dermatol Venereol. 2022 Mar 30 doi.org/10.1111/jdv.18118

A rare case of reactive granulomatous dermatitis during COVID-19: a possible role of cephalosporine and potential mechanisms

A. Aoki, M. Yamane, Y. Aoyama

J Eur Acad Dermatol Venereol. 2022 Mar 30 doi.org/10.1111/jdv.18119

Lessons from India’s COVID-19 crisis: Meyerozyma guillermondii presenting in a mucormycosis-like picture

M. Shanshal

J Eur Acad Dermatol Venereol. 2022 Apr 18 doi.org/10.1111/jdv.18159

Transient aquagenic syringeal acrokeratoderma during COVID-19 outbreak: a retrospective case series of eight patients

P. Burgos-Blasco,M. González-Cañete,A. Melian-Olivera,D. Vega-Diez,I. Aldanondo-Fernandez de la Mora,B. Perez-Garcia,D. De Perosanz-Lobo

J Eur Acad Dermatol Venereol. 2022 July 16 doi.org/10.1111/jdv.18434

Authors’ reply to: ‘Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine’

Martina Bertello,Giovanni Rubegni,Pietro Rubegni,Linda Tognetti

J Eur Acad Dermatol Venereol. 2022 August 14 doi.org/10.1111/jdv.18486

Authors’ reply to comment by Ciccarese et al. regarding ‘Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions’

Esperanza Welsh,Jesus Alberto Cardenas-de la Garza,Elizabeth Brussolo-Marroquín,Adrian Cuellar-Barboza,Rodolfo Franco-Marquez,Gerardo Ramos-Montañez

J Eur Acad Dermatol Venereol. 2022 August 20 doi.org/10.1111/jdv.18546

Comment on ‘Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions’

Giulia Ciccarese,Francesco Broccolo,Aurora Parodi,Francesco Drago

J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18498

COVID-19 induced pityriasis rubra pilaris: A superantigenic disease?

Italo Francesco Aromolo,Armando Pisapia,Davide Riva,Francesco Barberi,Angelo Valerio Marzano,Chiara Moltrasio,Maurizio Romagnuolo

J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18556

New insights on acral peeling dermatoses: An overlooked skin manifestation during COVID-19 pandemic

Iria Neri, Alba Guglielmo, Annalucia Virdi, Miriam Leuzzi, Bianca Maria Piraccini, Marco Adriano Chessa

J Eur Acad Dermatol Venereol. 2022 December 14 doi.org/10.1111/jdv.18815

Dupilumab treatment for severe atopic dermatitis in children and SARS-CoV-2 infection: A combination of triggers for psoriasis

Cristiana Colonna, Paolo Bortoluzzi, Riccardo Cavalli

J Eur Acad Dermatol Venereol. 16 January 2023 doi.org/10.1111/jdv.18864

Study of covid-19 vaccine-related cutaneous adverse events following immunization and establishing a causal association

Rohini Sharma

J Eur Acad Dermatol Venereol. 20 January 2023 doi.org/10.1111/jdv.18891

COVID-19-associated chilblain pruritus is non-histaminergic mediated and correlated to epidermal interleukin 31

Angelina Labib, Leigh Nattkemper, Ashley Vander Does, Teresa Ju, Sara Cacciapuoti, Maria Vastarella, Gabriella Fabbrocini, Gil Yosipovitch

J Eur Acad Dermatol Venereol. 14 February 2023 doi.org/10.1111/jdv.18970

Telogen effluvium in SARS-CoV-2 infection: Histological aspects

S. Michelini, G. Caro, M. Di Fraia, M. Fortuna, F. Magri, V. V. Gomes, T. Grieco, M. Carlesimo, A. Rossi, G. Pellacani

J Eur Acad Dermatol Venereol. 08 March 2023 doi.org/10.1111/jdv.19015

Sweet syndrome following SARS-CoV-2 infection: A unique bullous photo-distributed presentation

Cláudia Brazão, Dora Mancha, Luís Soares-de-Almeida, Paulo Filipe

J Eur Acad Dermatol Venereol. 13 March 2023 doi.org/10.1111/jdv.19038

Lingua villosa nigra in a child after COVID: Review and differential diagnosis with oral pigmentations of childhood

Vincenzo Piccolo, Andrea Bassi, Ramon Grimalt, Carlo Mazzatenta, Giuseppe Argenziano, Andrea Sechi, Mario Cutrone

J Eur Acad Dermatol Venereol. 27 March 2023 doi.org/10.1111/jdv.19070

Leprosy reactions after SARS-COV2 (COVID-19) infection

I. M. Gutiérrez-Villarreal, J. Ocampo-Candiani, A. Villarreal-Martinez, M. Gomez-Flores, L. T. Fernández, G. Rodríguez-Tamez, D. M. Pérez-Garza, G. González-Martínez, L. A. Yamallel-Ortega, S. Chavez-Alvarez

J Eur Acad Dermatol Venereol. 05 April 2023 doi.org/10.1111/jdv.19103

Acute generalized exanthematous pustulosis (AGEP) in a patient with COVID-19 infection

De Brucker, Laura; Seyler, Lucie; Leemans, Gaelle; Gutermuth, Jan; Grosber, Martine

J Eur Acad Dermatol Venereol. 15 April 2023 doi.org/10.1111/jdv.19119

A Case Of Eruptive Halo Nevi Following COVID-19

Ö. Gönüllü, F. Cebeci, T. Özen, M. S. Gürel, B. Ç. Şimşek

J Eur Acad Dermatol Venereol. 04 May 2023 doi.org/10.1111/jdv.19157

On the characterization of the effluvium following COVID-19 infection

A. C. Miola, P. M. Ramos, I. F. S. Mazeto, C. C. Brommonschenkel, H. A. Miot

J Eur Acad Dermatol Venereol. 06 May 2023 doi.org/10.1111/jdv.19166

A case of Covid-19-related vulval ulceration coupled with genital viral shedding

E. Mastoraki, S. Niforatou-Daskalaki, C. B. Bunker, G. Kravvas

J Eur Acad Dermatol Venereol. 17 May 2023 doi.org/10.1111/jdv.19212

Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection

S Skrek 1, V Di Lernia 2, A Beauchet 3, A-C Bursztejn 4, A Belloni Fortina 5, A Lesiak 6, J Thomas 7, P Brzezinski 8, Z Topkarci 9, N Murashkin 10, T Torres 11, R Epishev 10, A Chiriac 12, T McPherson 13, M Akinde 14, A Maruani 15, P C Luna 16, H Vidaurri de la Cruz 17, S Mallet 18, S Leducq 15, M Sergeant 4, J Zitouni 1, S K Mahil 19, C H Smith 14, C Flohr 13, H Bachelez 20 21, E Mahé 1; Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, the Groupe de recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), the PsoProtect study group, the British Society of Paediatric Dermatology, and the Società Italiana di Dermatologia Pediatrica (S.I.Der.P.)

J Eur Acad Dermatol Venereol. 16 June 2023 doi.org/10.1111/jdv.19261

Comment on: “Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination” by Gambichler.

Luca Potestio, Fabrizio Martora, Alessia Villani, Matteo Megna, Angelo Ruggiero

J Eur Acad Dermatol Venereol. 16 June 2023 doi.org/10.1111/jdv.19264

Bullous pemphigoid with autoantibodies against full-length BP180 protein after COVID-19 infection

Kazumasa Oya, Masakazu Kakurai, Kentaro Izumi, Norito Ishii, Toshifumi Nomura

J Eur Acad Dermatol Venereol. 20 July 2023 doi.org/10.1111/jdv.19373

Lichen planus pemphigoides after COVID-19 infection

D. Didona, Antonio M. Sequeira-Santos, J. Hinterseher, T. Cunha, M. Hertl

J Eur Acad Dermatol Venereol. 04 Oct 2023 doi.org/10.1111/jdv.19542

Reactive infectious mucocutaneous eruption secondary to COVID-19 infection: A case report and review of the literature

Georgia Koroneos, William Berry, Nicola Sweeney, Vanessa Morgan, Nur-Shirin Harun, Jenny Nicolopoulos

J Eur Acad Dermatol Venereol. 31 Oct 2023 doi.org/10.1111/jdv.19590

Secondary livedoid vasculopathy following SARS-CoV-2 infection

A. M. Carballido Vázquez, T. L. Vega López, P. Manchado López, G. Martínez García, A. Mateos Mayo

J Eur Acad Dermatol Venereol. 14 December 2023 doi.org/10.1111/jdv.19729

Skin manifestations of SARS-CoV-2 Omicron variant: Clinical, pathological, and immunological insights

Yuling Zhang, Yueming Mu, Bing Han, Rowida A. Albarmaqi, Huimin Wang, Yuemeng Zhao, Zhuang Tian, Jianxin Xia, Shanshan Li, Hong Wang, Aihua Fu, Hua Zheng, Yaping Tian

J Eur Acad Dermatol Venereol. 28 March 2024 doi.org/10.1111/jdv.19982

Guidelines and recommendations

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitisWollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16411European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactionsBalato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A. J Eur Acad Dermatol Venereol. 2020 Apr 30. doi: 10.1111/jdv.16557Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemicKasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16525Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M. J Eur Acad Dermatol Venereol. 2020 May 16. doi: 10.1111/jdv.16593European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologicsJ.P. Thyssen C. Vestergaard S. Barbarot M.S. de Bruin‐Weller T. Bieber A. Taieb J. Seneschal M.J. Cork C. Paul C. Flohr S. Weidinger M. Trzeciak T. Werfel A. Heratizadeh U. Darsow D. Simon A. Torrelo P.V. Chernyshov J.‐F. Stalder C. Gelmetti Z. Szalai Å. Svensson L.B. von Kobyletzki L. De Raeve R. Fölster‐Holst S. Christen‐Zaech D.J. Hijnen U. Gieler J. Gutermuth C. Bangert P.I. Spuls B. Kunz J. Ring A. Wollenberg M. Deleuran J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17167Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemicM. Kasperkiewicz, E. Schmidt, M. Amagai, J.A. Fairley, P. Joly, D.F. Murrell, A.S. Payne, M.L. Yale, D. Zillikens, D.T. Woodley J Eur Acad Dermatol Venereol. 2021 Mar 2 doi.org/10.1111/jdv.17207Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19M. Arenbergerova, A. Lallas, E. Nagore, L. Rudnicka, A. Forsea, M. Pasek, F. Meier, K. Peris, J. Olah, C. Posch J Eur Acad Dermatol Venereol. 2021 Mar 29 doi.org/10.1111/jdv.17252

Biologics and immunomodulatory therapies

Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?Di Altobrando A, Patrizi A, Bardazzi F. J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16491SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor Messina F, Piaserico S. J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16468Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S. J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16527No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area – Bergamo, Lombardy, ItalyCarugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, Robustelli Test E, Sena P. J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16552“Toxic Erythema” and Eosinophilia Associated to Tocilizumab Therapy in a COVID-19 PatientSernicola A, Carnicelli G, Di Fraia M, Chello C, Furlan C, Muharremi R, Paolino G, Grieco T. J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16620Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugsConti A, Lasagni C, Bigi L, Pellacani G. J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16587Improvement of SARS-CoV2 symptoms following guselkumab injection in a psoriatic patientBenhadou F, Del Marmol V. J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16590SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab Caroppo F, Biolo G, Belloni Fortina A. J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16619SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitorBalestri R, Rech G, Girardelli CR J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16571Prior treatment with immunosuppressants among COVID-19 inpatients in one hospital in SpainPastor-Nieto MA, Checa-Díaz P, González-Muñoz P, Martín-Fuentes A, Vergara-Sánchez A, Sánchez-Herreros C, Jiménez-Blázquez E, Cabana-Navia R, Martínez-Mariscal J, Cobo-Rodríguez P, Checa-Recio I, Gatica-Ortega ME, Torralba M, De Eusebio-Murillo E J Eur Acad Dermatol Venereol. 2020 Jun 28. doi.org/10.1111/jdv.16798Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19Fougerousse AC, Perrussel M, Bécherel PA, Begon E, Pallure V, Zaraa I, Chaby G, Parier J, Kemula M, Mery-Bossard L, Poreaux C, Taieb C, Maccari F, Reguiai Z; GEM Resopso J Eur Acad Dermatol Venereol. 2020 Jun 21. doi: 10.1111/jdv.16761Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: A multicenter study in the Czech RepublicRob F, Hugo J, Tivadar S, Boháč P, Gkalpakiotis S, Vargová N, Arenbergerová M, Hercogová J. J Eur Acad Dermatol Venereol. 2020 Jun 27. doi: 10.1111/jdv.16771Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with Intravenous Immunoglobulin: “Killing 2 birds with one stone”Saha M, D’Cruz A, Paul N, Healy R, Collins D, Charles DA, Sahu S, Fonia A. J Eur Acad Dermatol Venereol. 2020 Aug 17. doi: 10.1111/jdv.16887Position Statement for a Pragmatic Approach to Immunotherapeutics in Patients with Inflammatory Skin Diseases during the COVID-19 Pandemic and BeyondJ. Beecker K.A. Papp J. Dutz R.B. Vender R. Gniadecki C. Cooper P. Gisondi M. Gooderham C.H. Hong M.G. Kirchhof C.W. Lynde C. Maari Y. Poulin L. Puig J Eur Acad Dermatol Venereol. 2021 Feb 3 doi.org/10.1111/jdv.17075Understanding Views of Patients on Biologics for Psoriasis Amid the COVID-19 Pandemic K. Pandher C.L. Porter H.S. Patel W.W. Huang S.R. Feldman J Eur Acad Dermatol Venereol. 2020 Nov 17 doi.org/10.1111/jdv.17091Good tolerance of hyaluronic acid injections during the Covid-19 pandemic period: a prospective observational real-life study of a cohort of 1093 patients with a 3 month-follow up periodMichael Naouri Serge Dahan Anne Le Pillouer Prost Phrynée Coutant‐Foulc Catherine Raimbault Françoise Cucurella Laurence Beille Muriel Creusot Martine Baspeyras Martine Darchy Randa Khallouf Hugues Cartier Isabelle Baratte Magali Dubois Olivier Cogrel Hans Laubach Groupe de Dermatologie Esthétique et Correctrice de la Société Française de Dermatologie (GDEC) J Eur Acad Dermatol Venereol. 2021 Apr 8 doi.org/10.1111/jdv.17271Autoantibodies in Covid19 – A model for viral induced autoimmunityJ. Berger, S. Volc J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17396SARS-CoV-2 Serology In Patients On Biological Therapy or Apremilast For Psoriasis: A Study of 93 Patients in the Italian Red ZoneSyed M. A. Ahmed,Martina Volontè,Eugenio Isoletta,Camilla Vassallo,Carlo Francesco Tomasini,Daniele Lilleri,Paola Zelini,Valeria Musella,Catherine Klersy,Valeria Brazzelli J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17721

Clinical set-up and service delivery

Pitfalls of possible reporting of same patients with COVID-19 in various dermatology journals
Kluger N.
J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16690

SARS-CoV, Mers-CoV and Covid-19: : what differences from a dermatological viewpoint?
Rongioletti F.
J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16738

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic
Chernyshov PV, Tomas-Aragones L, Augustin M, Svensson A, Bewley A, Poot F, Szepietowski JC, Marron SE, Manolache L, Pustisek N, Suru A, Salavastru CM, Blome C, Salek MS, Abeni D, Sampogna F, Dalgard F, Linder D, Ewers A, Finlay AY.
J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16720

Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men
Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16953.

Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients
McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16956

SARS-CoV-2 spike protein in a chilblain-like skin lesion is present in both endothelial and eccrine cells
T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres‐Reyes, R. Schlottmann, W.E. Schmidt, R. Hayajneh, A. Sriram, J.C. Becker
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi.org/10.1111/jdv.16970

Cross-country comparisons of Google searches for chilblains before and during the COVID-19 pandemic

SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations
B Cribier, C Taieb, M Saint Aroman, J Shourick
J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17380

Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study
SK Mahil, M Yates, ZZN Yiu, SM Langan, T Tsakok, N Dand, KJ Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, H Bachelez, F Capon, CR Contreras, C De La Cruz, P Di Meglio, P Gisondi, D Jullien, J Lambert, L Naldi, S Norton, L Puig, P Spuls, T Torres, RB Warren, H Waweru, J Weinman, MA Brown, JB Galloway, CM Griffiths, JN Barker, CH Smith, On behalf of the PsoProtect study group
J Eur Acad Dermatol Venereol. 2021 Jun 17 com/doi/10.1111/jdv.17450

Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak
E.J. Chun, J.K. Kim, S.Y. Yang, S.S. Kim, C.W. Kim
J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17640

Estimating the incidence of Cutaneous COVID-19 reactions on the general population in a territorial setting
C. Zengarini, A. Guglielmo, M. Giovani, C. Preci, E. Dika, B.M. Piraccini, A. Pileri
J Eur Acad Dermatol Venereol. 2022 Jan 26 doi.org/10.1111/jdv.17970

Prevalence and patterns of cutaneous manifestations in 1245 COVID-19 patients in Japan: a single-centre study

T. Sugai, Y. Fujita, E. Inamura, Y. Maya, S. Shimizu
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18062

Ultrastructural evidence for anagen hair follicle infection with SARS-CoV-2 in early-onset COVID-19 effluvium
I.F.S. Mazeto,C.C. Brommonschenkel,A.C. Miola,P. Müller Ramos,D. Carvalho dos Santos,H.A. Miot
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16690

A spectrum of leprosy reactions triggered by Covid-19 vaccination: a series of four cases

N. Saraswat,D. M. Tripathy,S. Kumar,P. Awasthi,M. M. Gopal
J Eur Acad Dermatol Venereol. 2022 June 29 doi.org/10.1111/jdv.16738

Reply to ‘Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study’. by Bawane J et al

L. Potestio,L. Genco,A. Villani,C. Marasca,G. Fabbrocini,L. Fornaro,A. Ruggiero,F. Martora
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16720

Face mask-induced purpura: another unexpected effect of COVID era

V. Piccolo,A. Bassi,C. Mazzatenta,T. Russo,G. Argenziano,M. Cutrone,Markus ES Danielsson Darlington,R. Grimalt
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18392

Effects of COVID-19 pandemic on malignant melanoma diagnosis

Alessia Villani,Massimiliano Scalvenzi,Gabriella Fabbrocini,Luigi Fornaro,Gianluca Guerrasio,Luca Potestio
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18545

Despite the use of ivermectin during the COVID pandemic, scabies keeps playing tricks with us

Juliana Polizel Ocanha-Xavier,José Cândido Caldeira Xavier-Junior
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18547

Coronavirus aetiology, severity and transmission

5-Alpha-Reductase Inhibitors are Associated with Reduced Frequency of COVID-19 Symptoms in Males with Androgenetic Alopecia

J. McCoy F.A. Cadegiani C.G. Wambier S. Herrera S. Vaño‐Galván N.A. Mesinkovska P.M. Ramos J. Shapiro R. Sinclair A. Tosti A. Goren
J Eur Acad Dermatol Venereol. 2020 Nov 2 doi.org/10.1111/jdv.17021

Extraordinary claims without extraordinary evidence Controversy on Anti-Androgen Therapy for COVID-19

R.M. Trüeb A. Régnier N. Caballero‐Uribe M.F. Reis Gavazzoni Dias H. Dutra Rezende
J Eur Acad Dermatol Venereol. 2021 Mar 30 doi.org/10.1111/jdv.17249

Prevalence and characteristics of dermatological manifestations in COVID-19 positive dermatologists: Report from a web-based survey in India

Deepak Jakhar, Anupam Das, Subuhi Kaul, Ishmeet Kaur, Bhushan Madke, Ashish Dalal
J Eur Acad Dermatol Venereol. 2021 Jul 23 com/doi/10.1111/jdv.17532

Late-onset pustular skin eruption in a healthy neonate born from COVID-positive mother: a coincidence or a new skin sign of the infection?

V. Piccolo, C. Mazzatenta, T. Russo, F. Morandi, A. Bassi, G. Argenziano, E. Valerio, R. Grimalt, M. Cutrone
J Eur Acad Dermatol Venereol. 2021 Aug 7 doi/abs/10.1111/jdv.17579

Aquagenic Keratoderma as a consequence of excessive handwashing during the COVID-19 Pandemic – A Case Report

Raquel Falcão de Freitas, António Freitas

J Eur Acad Dermatol Venereol. 23 August 2023 doi.org/10.1111/jdv.19459

Coronavirus drugs

Prompt onset of erythema multiforme following the first BNT162b2 SARS-CoV-2 vaccination

T. Gambichler L. Scholl L. Ocker R. Stranzenbach
J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17225

Lichen planus arising after COVID-19 vaccination
I. Hiltun J. Sarriugarte I. Martínez‐de‐Espronceda A. Garcés C. Llanos R. Vives J.I. Yanguas
J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17221

Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine
M. Ackerman D. Henry A. Finon R. Binois E. Esteve
J Eur Acad Dermatol Venereol. 2021 Mar 30 doi.org/10.1111/jdv.17248

Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. “COVID-arm”: a clinical and histological characterization

D. Fernandez‐Nieto J. Hammerle M. Fernandez‐Escribano CM Moreno‐del Real P. Garcia‐Abellas I. Carretero‐Barrio E. Solano‐Solares B de‐la‐Hoz‐Caballer J. Jimenez‐Cauhe D. Ortega‐Quijano M. Fernandez‐Guarino
J Eur Acad Dermatol Venereol. 2021 Mar 30 doi.org/10.1111/jdv.17250

Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report

E. Akdaş N. İlter B. Öğüt Ö. Erdem
J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17316

BNT162b2 mRNA Covid-19 Vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2
V. Piccolo, A. Bassi, G. Argenziano, C. Mazzatenta, M. Cutrone, I. Neri, R. Grimalt, T. Russo
J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17320

Anaphylaxis to vaccination and polyethylene glycol (PEG): A perspective from the European Anaphylaxis Registry

M Kraft, JM Renaudin, LF Ensina, A Kleinheinz, MB Bilò, K Scherer Hofmeier, S Dölle-Bierke, M Worm
J Eur Acad Dermatol Venereol. 2021 Apr 29 doi/abs/10.1111/jdv.17327

Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy
E. Farinazzo, G. Ponis, E. Zelin, E. Errichetti, G. Stinco, C. Pinzani, A. Gambelli, N. De Manzini, L. Toffoli, A. Moret, M. Agozzino, C. Conforti, N. Di Meo, P. Schincariol, I. Zalaudek
J Eur Acad Dermatol Venereol. 2021 May 22 doi/abs/10.1111/jdv.17343

Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine
Benoit Cyrenne, Faisal Al-Mohammedi, Joel DeKoven, Raed Alhusayen
J Eur Acad Dermatol Venereol. 2021 May 13 com/doi/10.1111/jdv.17342

Purpuric lesions on the eyelids developed after BNT162b2 mRNA Covid-19 Vaccine: another piece of SARS-CoV-2 skin puzzle?
C. Mazzatenta, V. Piccolo, G. Pace, I. Romano, G. Argenziano, A. Bassi
J Eur Acad Dermatol Venereol. 2021 May 28 oi/full/10.1111/jdv.17340

Ipsilateral Herpes Zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine

I. Tessas, N. Kluger
J Eur Acad Dermatol Venereol. 2021 May 31 oi/full/10.1111/jdv.17422

SARS-CoV-2 mRNA Vaccine-Associated Fixed Drug Eruption
Dillon Mintoff, David Pisani, Alexandra Betts, Lawrence Scerri
J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17390

Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine

P. K. Krajewski, J. C. Szepietowski
J Eur Acad Dermatol Venereol. 2021 Jun 2 com/doi/10.1111/jdv.17444

Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2

C. Lesort, J. Kanitakis, L. Donzier, D. Jullien
J Eur Acad Dermatol Venereol. 2021 Jun 16 com/doi/10.1111/jdv.17451

Systemic drug-related intertriginous and flexural exanthema like eruption after CoronaVac vaccineO.M. Orenay, I. Balta, D. Yigit, M. Eksioglu
J Eur Acad Dermatol Venereol. 2021 Jun 17 oi/10.1111/jdv.17454?af=R

Psoriasis flare up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccineP.K. Krajewski, Ł. Matusiak, J.C. Szepietowski
J Eur Acad Dermatol Venereol. 2021 Jun 16 com/doi/10.1111/jdv.17449

First dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose contraindicated?G. Damiani, A. Pacifico, F. Pelloni, M. Iorizzo
J Eur Acad Dermatol Venereol. 2021 Jun 25 com/doi/10.1111/jdv.17472

Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’?J.E. Kim, H. Lee, S.S. Paik, J.-Y. Moon, H.J. Yoon, S.-H. Kim
J Eur Acad Dermatol Venereol. 2021 Jun 24 com/doi/10.1111/jdv.17476

Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2F. Solimani, Y. Mansour, D. Didona, A. Dilling, K. Ghoreschi, K. Meier
J Eur Acad Dermatol Venereol. 2021 Jun 25 com/doi/10.1111/jdv.17480

Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccineN. Cameli, M. Silvestri, M. Mariano, S.P. Nisticò, A. Cristaudo
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17500

Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccinationA. Kreuter, S.-N. Burmann, B. Burkert, F. Oellig, A.-L. Michalowitz
J Eur Acad Dermatol Venereol. 2021 Jul 9 oi/full/10.1111/jdv.17514

Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccineD. Falkenhain-López, C. Gutiérrez-Collar, J. Arroyo-Andrés, I. Gallego-Gutiérrez, J.L. Rodríguez-Peralto, A. Sánchez-Velázquez
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17497

‘COVID arm’ – histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccineW. Kempf, N. Kettelhack, F. Kind, S. Courvoisier, J. Galambos, K. Pfaltz
J Eur Acad Dermatol Venereol. 2021 Jul 9 oi/full/10.1111/jdv.17506

Erythema multiforme after CoronaVac vaccinationN.T. Lopes, C.E.O. Pinilla, A.C. Gerbase
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17495

New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination
L. Quattrini, L. Verardi, G. Caldarola, G. Peluso, C. De Simone, M. D’Agostino
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17502

Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine
A.C. Leasure, S.E. Cowper, J. McNiff, J.M. Cohen
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17494

New-onset cutaneous lichen planus triggered by COVID-19 vaccinationR. Merhy, A.-S. Sarkis, J. Kaikati, L. El Khoury, S. Ghosn, F. Stephan
J Eur Acad Dermatol Venereol. 2021 Jul 8 oi/full/10.1111/jdv.17504

Pityriasis rosea developing after COVID-19 vaccinationO.Y. Marcantonio-Santa Cruz, A. Vidal-Navarro, D. Pesqué, A.M. Giménez-Arnau, R.M. Pujol, G. Martin-Ezquerra
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17498

Herpes Zoster following SARS-CoV-2 vaccination – a series of four casesM. Alpalhão, P. Filipe
J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17555

Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2L. Guzmán-Pérez, M. Puerta-Peña, D. Falkenhain-López, J. Montero-Menárguez, C. Gutiérrez-Collar, J.L. Rodríguez-Peralto, J. Sanz-Bueno
J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17547

New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: clinical images and histopathological study of three casesD. Revilla-Nebreda, M. Roncero-Riesco, Á. Santos-Briz, M. Medina-Migueláñez, N. Segurado-Tostón, C. Román-Curto
J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17553

Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccineF. Nastro, G. Fabbrocini, F. di Vico, C. Marasca
J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17550

Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccineA. Smola, S. Samazadeh, L. Müller, O. Adams, B. Homey, P. Albrecht, S. Meller
J Eur Acad Dermatol Venereol. 2021 Jul 26 doi/abs/10.1111/jdv.17549

New onset of mainly guttate psoriasis after COVID-19 vaccination: a case reportM. Lehmann, P. Schorno, R.E. Hunger, K. Heidemeyer, L. Feldmeyer, N. Yawalkar
J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17561

A skin reaction with rust-like discolouration to mRNA COVID-19 vaccineR. Pasternack, S. Pohjavaara
J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17543

Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine
Iñigo Lladó, Beatriz Butrón-Bris, Raquel Sampedro-Ruiz, Javier Fraga, Diego de Argila
J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17542

Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the PhilippinesJ.N. Yu, C.B. Angeles, H.G. Lim, C. Chavez, C. Roxas-Rosete
J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17575

Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case seriesM. Vastarella, V. Picone, F. Martora, G. Fabbrocini
J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17576

Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine)L. Juay, N.S. Chandran
J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17581

Cutaneous reactions following CoronaVac COVID-19 vaccination: a case series of six healthcare workers from a single centreE. Akdaş, B. Öğüt, Ö. Erdem, M.O. Öztaş, N. İlter
J Eur Acad Dermatol Venereol. 2021 Aug 9 oi/full/10.1111/jdv.17592

Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literatureE. Annabi,N. Dupin,P. Sohier,B. Garel,N. Franck,S. Aractingi,S. Guégan,B. Oulès
J Eur Acad Dermatol Venereol. 2021 Aug 7 doi.org/10.1111/jdv.17578

Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults
A.K. Özdemir, S. Kayhan, S.K. Çakmak
J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17577

Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centreE. Sotiriou, A. Tsentemeidou, K. Bakirtzi, A. Lallas, D. Ioannides, E. Vakirlis
J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17582

Erythema gyratum repens after COVID-19R. Castro Silva, G. Castro Silva, M.C. Castro Silva, O. Lupi
J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17583

A Bullous Eruption following the Pfizer-BioNTech COVID-19 vaccinationA. D’Cruz,H. Parker,M. Saha
J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17606

Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinationsG. Ciccarese,F. Drago,A. Rebora,A. Parodi
J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17615

‘COVID vaccine arm’ may present after both mRNA vaccines vaccinationS. Gregoriou,I. A. Kleidona,A. Tsimpidakis,E. Nicolaidou,A. Stratigos,D. Rigopoulos
J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17614

Flagellate purpura associated with COVID-19 vaccinationE. Heck,B.D. Rankin,M. Schneider,V.H. Prajapati
J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17609

Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccinesM. Tihy,S. Menzinger,R. André,E. Laffitte,L. Toutous-Trellu,G. Kaya
J Eur Acad Dermatol Venereol. 2021 Aug 30 com/doi/10.1111/jdv.17633

Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccineL. Huang, Z. Yao, J. Zhang
J Eur Acad Dermatol Venereol. 2021 Sep 7 oi/full/10.1111/jdv.17648

Varicella Zoster and Herpes Simplex Virus Reactivation Post-COVID-19 Vaccination: A Review of 40 Cases in an International Dermatology RegistryRamie A. Fathy,Devon E. McMahon,Cynthia Lee,Grace C. Chamberlin,Misha Rosenbach,Jules B. Lipoff,Anisha Tyagi,Seemal R. Desai,Lars E. French,Henry W. Lim,Bruce H. Thiers,George J. Hruza,Marlys Fassett,Lindy P. Fox,Harry L. Greenberg,Kimberly Blumenthal,Esther E. Freeman
J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17646

COVID vaccine-induced lichen planus on areas previously affected by vitiligoVincenzo Piccolo,Carlo Mazzatenta,Andrea Bassi,Giuseppe Argenziano,Mario Cutrone,Ramon Grimalt,Teresa Russo
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17687

Erythema multiforme after SARS-CoV-2 vaccineLi-wen Zhang,Wen-ju Wang,Cong-hui Li,Tao Chen
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17689

New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin?David Pesqué,Emilio Lopez-Trujillo,Orianna Marcantonio,Ana Maria Giménez-Arnau,Ramon Maria Pujol
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17690

Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccineLaurence de Montjoye,Liliane Marot,Marie Baeck
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17685

Pfizer-BioNTech SARS-CoV-2 mRNA Vaccine-associated Erythema MultiformeLuca Borg,Liam Mercieca,Dillon Mintoff,Daniel Micallef,David Pisani,Alexandra Betts,Lawrence Scerri
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17682

Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford–AstraZeneca COVID-19 vaccine: report of three cases from IndiaHitaishi Mehta,Sanjeev Handa,Pankaj Malhotra,Meenakshi Patial,Smriti Gupta,Anirudh Mukherjee,Debajyoti Chatterjee,Aastha Takkar,Rahul Mahajan
J Eur Acad Dermatol Venereol. 2021 Sep 21 doi/abs/10.1111/jdv.17678

Early atypical injection-site reactions to COVID-19 vaccine: a case seriesM. Vaccaro,L. Bertino,R. Squeri,C. Genovese,S. Isola,G. Spatari,E. Spina,P. Cutroneo
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17683

Nevocentric erythema multiforme after SARS-COV-2 VaccineC. Scharf,E. V. di Brizzi,S. Pellerone,M. Liguori,C.M.R. Giorgio,G. Argenziano
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17688

SARS-CoV-2 mRNA Vaccine Injection Site PseudolymphomaDillon Mintoff,Lawrence Scerri,Alexandra Betts

J Eur Acad Dermatol Venereol. 2021 Sep 21 oi/10.1111/jdv.17680?af=R

A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccineJ. Young,L. Mercieca,M. Ceci,D. Pisani,A. Betts,M.J. Boffa
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17676

Recurrence of Cutaneous T-cell lymphoma (CTCL) post viral vector COVID-19 vaccinationE Panou,V Nikolaou,L Marinos,S Kallambou,P Sidiropoulou,M Gerochristou,A Stratigos
J Eur Acad Dermatol Venereol. 2021 Oct 10 doi.org/10.1111/jdv.17736

Development of oral lichen planus after COVID-19 vaccination – a rare case reportP. Sharda, A. Mohta, B.C. Ghiya, R.D. Mehta
J Eur Acad Dermatol Venereol. 2021 Oct 4 oi/full/10.1111/jdv.17718

Eruptive angiomatosis after SARS-CoV-2 Vaccine (Comirnaty, Pfizer)Corrado Zengarini,Cosimo Misciali,Tiziana Lazzarotto,Emi Dika
J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17723

Biphasic bullous pemphigoid starting after first dose and boosted by second dose of mRNA-1273 vaccine in an 84-year-old female with polymorbidity and polypharmacyV. Schmidt,R. Blum,M. Möhrenschlager
J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17722

Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case seriesD. Koumaki,S.-E. Krueger-Krasagakis,M. Papadakis,A. Katoulis,V. Koumaki,G. Evangelou,M. Stefanidou,D. Mylonakis,K. Zografaki,K. Krasagakis
J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17720

Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidence
S.G. Brooks,R. Alhusayen,V. Piguet,D. Croitoru
J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17719

Cutaneous findings following COVID-19 vaccination: Review of world literature and own experienceThilo Gambichler,Stefanie Boms,Laura Susok,Heinrich Dickel,Cansu Finis,Nessr Abu Rached,Milan Barras,Markus Stücker,Dimitri Kasakovski
J Eur Acad Dermatol Venereol. 2021 Oct 17 doi.org/10.1111/jdv.17744

Comment on “Development of eruptive pseudoangiomatosis following COVID-19 inmunization-apropos of 5 cases”: could eruptive pseudoangiomatosis represent a paraviral eruption associated with SARS-CoV-2?Cristina Moya-Martinez,Emilio de Dios Berná-Rico,Ana Melian-Olivera,Carmen Moreno-Garcia del Real,Diego Fernández-Nieto
J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17750

Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech)Minjae Kim,Jee Woo Kim,Minsu Kim,Sun Young Choi,Jung-Im Na
J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17757

Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanomaManon Blaise,Fanny Rocher,Hélène Spittler,Adrien Sanchez,Elisabeth Lanteri,Lucia Coco,Angela Puma,Arnaud Martel,Geraldine Gonfrier,Thierry Passeron,Henri Montaudié
J Eur Acad Dermatol Venereol. 2021 Oct 17 doi.org/10.1111/jdv.17760

Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: A prospective cohort study in healthcare workersPawinee Rerknimitr,Thanaporn Puaratanaarunkon,Chanidapa Wongtada,Namthong Wittayabusarakam,Saran Krithin,Leilani Paitoonpong,Chanat Kumtornrut,Stephen J Kerr,Pravit Asawanonda,Watsamon Jantarabenjakul,Jettanong Klaewsongkram
J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17761

Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccineNorma Cameli,Martina Silvestri,Maria Mariano,Luigi Bennardo,Steven Paul Nisticò,Antonio Cristaudo
J Eur Acad Dermatol Venereol. 2021 Oct 18 com/doi/10.1111/jdv.17762

Response to ‘A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine
C Kouki,K Sellami,E Bahloul,M Amouri,A Masmoudi,H Turki
J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17751

Regression of common viral warts after ChAdOx1-S COVID-19 vaccineAnna Płaszczyńska,Martyna Sławińska,Michał Sobjanek
J Eur Acad Dermatol Venereol. 2021 Oct 26 doi.org/10.1111/jdv.17771

Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruptionA. Sernicola,A. Dybala,V. Gomes,P. Maddalena,F. Adotti,G. Soda,R. Muharremi,P. Fino,E. Del Duca,T. Grieco
J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17807

Eosinophilic dermatosis after AstraZeneca COVID-19 vaccinationE. Cinotti,J.-L. Perrot,F. Bruzziches,L. Tognetti,A. Batsikosta,E. Sorrentino,A.V. Marzano,P. Rubegni
J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17806

Reply to “New-onset cutaneous lichen planus triggered by COVID-19 vaccination” by Merhy et al
E. Camela,G. Guerrasio,C. Patruno,M. Scalvenzi,N. Di Caprio,G. Fabbrocini,M. Napolitano
J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17866

Emergence of Behçet’s disease post-SARS-CoV2-vaccination: two clinical cases in JapanH. Hashizume,S. Ajima,Y. Ishikawa
J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17859

Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patientG.V. Knechtl,S.M. Seyed Jafari,T. Berger,A. Rammlmair,L. Feldmeyer,L. Borradori
J Eur Acad Dermatol Venereol. 2021 Dec 12 doi.org/10.1111/jdv.17868

Exuberant lichenoid eruption after Oxford–AstraZeneca COVID-19 vaccine: a singular caseC. Correia,S. Fernandes,L. Soares-de-Almeida,P. Filipe
J Eur Acad Dermatol Venereol. 2021 Dec 16 doi.org/10.1111/jdv.17872

Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19)C. Masseran,A. Calugareanu,F. Caux,G. Bohelay
J Eur Acad Dermatol Venereol. 2021 Dec 21 doi.org/10.1111/jdv.17899

Lichen planus after CoronaVac: a rare complication of vaccines A. Satılmış Kaya,N. Cemşitoğlu,E. Adışen,Ö. Erdem
J Eur Acad Dermatol Venereol. 2022 Jan 6 doi.org/10.1111/jdv.17906

Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature reviewM. Pauluzzi,G. Stinco,E. Errichetti
J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17891

Cutaneous manifestations following COVID-19 vaccination: a multicentric descriptive cohortE. Massip,P. Marcant,G. Font,S. Faiz,S. Duvert-Lehembre,I. Alcaraz,A. Vermersch-Langlin,M. Véron,C. Macaire,K. Faure,F. Vuotto,D. Staumont-Sallé,F. Dezoteux
J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17883

SCLE manifestation after mRNA COVID-19 vaccinationL. Rechtien,C. Erfurt-Berge,M. Sticherling
J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17895

Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccinationA. Kuzumi,A. Yoshizaki,K. Chiba,S. Mitsuo,K.M. Matsuda,Y. Norimatsu,K. Nagai,J. Omatsu,T. Miyake,S. Sato
J Eur Acad Dermatol Venereol. 2021 Nov 28 doi.org/10.1111/jdv.17837

Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID-19 vaccination and the creation of a locus minoris resistentiaeA.L. Tatu,T. Nadasdy,L.C. Nwabudike
J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17864

Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccineJ. Kaikati,A. Ghanem,R. El Bahtimi,J. Helou,R. Tomb
J Eur Acad Dermatol Venereol. 2022 Jan 12 doi.org/10.1111/jdv.17920

COVID vaccine-induced pustular psoriasis in patients with previous plaque type psoriasisV. Piccolo,T. Russo,C. Mazzatenta,A. Bassi,G. Argenziano,M. Cutrone,M. E. S. Danielsson Darlington,R. Grimalt
J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17918

COVID vaccine-induced reaction around molluscum contagiosum with secondary partial clearance of lesions
V. Piccolo,A. Bassi,C. Mazzatenta,G. Argenziano,M. Cutrone,R. Grimalt,T. Russo
J Eur Acad Dermatol Venereol. 2022 Jan 12 doi.org/10.1111/jdv.17919

Stevens-Johnson Syndrome induced by Vaxvetria (AZD1222) Covid-19 vaccineC. Aimo,E.B. Mariotti,A. Corrà,E. Cipollini,O. Le Rose,C. Serravalle,N. Pimpinelli,M. Caproni
J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17988

Pityriasis Lichenoides et Varioliformis Acuta Following COVID-19 mRNA VaccinationJ. Palmén,M. Lepistö,L. Talve,N. Hieta
J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17912

Cutaneous Reactions due to Pfizer’s BNT162b2 mRNA and Moderna’s mRNA-1273 VaccinesA. Oulee,S. Salem,R. Yahia,K. Yang,D. Garcia,A. Holmes,B. Furukawa
J Eur Acad Dermatol Venereol. 2022 Jan 13 doi.org/10.1111/jdv.17925

Wells’ syndrome following Oxford–AstraZeneca COVID-19 vaccinationY. H. Kim,Y. C. Kim
J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17916

Trigger of Type 2 Lepra reaction with acute foot drop following Covid-19 vaccination
A.K. Panda,F. Begum,M. Panda,A.K. Jena
J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17915

Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centreD. Koumaki,S.-E. Krueger-Krasagakis,M. Papadakis,A.C. Katoulis,I. Gkiaouraki,K. Zografaki,D. Mylonakis,K. Krasagakis
J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17965

Reply to “The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?” by Damiani G et al.G. Avallone,S. Giordano,C. Astrua,M. Merli,R. Senetta,C. Conforti,S. Ribero,A.V. Marzano,P. Quaglino
J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17959

A first case of “Covid toes” from a viral vector-based COVID-19 vaccineA. Van Loon,D. Mortelmans,V. Siozopoulou,B. Ogunjimi,H. Jansens,J. Lambert,O. Aerts
J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17948

Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccinationT. Ogawa,U. Aitake,T. Nomura
J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17947

A study of COVID-19 vaccine (Covishield) induced dermatological adverse effects from IndiaP. Das,S. Arora,G.K. Singh,P. Bellad,R. Rahman,A. Bahuguna,D. Sapra,R. Shrivastav,A. Gupta
J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17951

Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccinationW.-K. Hung,C.-C. Chi
J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17955

“COVID nose” – a unique post-COVID pigmentary sequelae reminiscing Chik sign: a descriptive case seriesA. Sil,A. Panigrahi,A. Chandra,J.D. Pramanik
J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17989

Reply to “COVID vaccine-induced lichen planus on areas previously affected by vitiligo”E. Bularca,J. Monte-Serrano,P. Villagrasa-Boli,A. Lapeña-Casado,S. de-la-Fuente
J Eur Acad Dermatol Venereol. 2022 Feb 11 doi.org/10.1111/jdv.18001

Development of eruptive pseudoangiomatosis following immunization with COVISHIELD vaccine in an adultT. Prarthana,S. Bakshi,V. Hanumanthu,U. Nahar,D. De
J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17990

Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 Vaccine in a patient with primary biliary cholangitisC. Zengarini,A. Pileri,F.P. Salamone,B.M. Piraccini,G. Vitale,M. La Placa
J Eur Acad Dermatol Venereol. 2021 Nov 22 doi.org/10.1111/jdv.17827

Not only toes and fingers: COVID vaccine-induced chilblain-like lesions of the kneesA. Bassi,C. Mazzatenta,A. Sechi,M. Cutrone,V. Piccolo
J Eur Acad Dermatol Venereol. 2022 Feb 21 doi.org/10.1111/jdv.18025

A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccineS. Ohmura,S. Hanai,R. Ishihara,Y. Ohkubo,T. Miyamoto
J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18013

Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopeniaY.-T. Hung,Y.-L. Huang,Y.-Y. Chang,W.-T. Chen
J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18014

Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccinationT. Mäkilä,L. Jeskanen,M. Butina,L. Harjama,A. Ranki,T. Mälkönen,N. Kluger
J Eur Acad Dermatol Venereol. 2022 Feb 19 doi.org/10.1111/jdv.18024

Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumabG. Pavia,L. Gargiulo,F. Spinelli,J. Avagliano,M. Valenti,R. G. Borroni,A. Costanzo,A. Narcisi
J Eur Acad Dermatol Venereol. 2022 Feb 27 doi.org/10.1111/jdv.18032

Association between vaccination and immunobullous disorders: a brief, updated systematic review with focus on COVID-19M. Kasperkiewicz,D.T. Woodley
J Eur Acad Dermatol Venereol. 2022 Feb 26 doi.org/10.1111/jdv.18030

Erythema nodosum leprosum post-COVID-19 vaccination: endemic while pandemicT. Fachler,K. Olshtain-Pops,L. Horev
J Eur Acad Dermatol Venereol. 2022 Feb 28 doi.org/10.1111/jdv.18035

Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoinP.R. Criado,M. Ianhez,P.S. Rocha,H.A. Miot
J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18055

Erythema gyratum repens after COVID vaccinationD. Chiquito,J.C.C. Xavier-Junior,G. Peres,O. Lupi
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18061

Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19)C. Ben Salem,A. Khelif,D. Sahnoun,N. Ghariani,B. Sriha,M. Denguezli
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18059

Case of lichen planus pigmentosus–inversus after Oxford–AstraZeneca COVID-19 vaccine: cause or coincidence?L. Sun,S. Duarte,L. Soares-de-Almeida
J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18058

Two cases of anti-TIF1-γ antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination
A. Yoshida,T. Ikegami,K. Igawa
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18060

Erythema multiforme in COVID-19 patients and following COVID-19 vaccination: manifestations, associations and outcomesF. Etaee,M. Eftekharian,T. Naguib,S. Daveluy
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18063

Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccine
I. Lahouel,N. Ben Salah,N. Ben Fadhel,F. Chahed,N. Ouni,H. Belhadjali,K. Aouem,J. Zili
J Eur Acad Dermatol Venereol. 2022 Mar 28 doi.org/10.1111/jdv.18108

Transient inflammation in surgical scars following Covid-19 mRNA vaccinationC. Ferreli,J. Anedda,L. Atzori
J Eur Acad Dermatol Venereol. 2022 Mar 19 doi.org/10.1111/jdv.18088

De novo annular pustular psoriasis following mRNA COVID-19 vaccineM. Romagnuolo,P. Pontini,S. Muratori,A. V. Marzano,C. Moltrasio
J Eur Acad Dermatol Venereol. 2022 Mar 29 doi.org/10.1111/jdv.18114

Commentary on ‘Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine’D. Turkmen,N. Altunisik
J Eur Acad Dermatol Venereol. 2022 Mar 30 doi.org/10.1111/jdv.18117

Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from BrazilC.A. Seque,M.M.S.S. Enokihara,M.M. Nascimento,A.M. Porro,J. Tomimori
J Eur Acad Dermatol Venereol. 2022 Mar 29 doi.org/10.1111/jdv.18112

Haemorrhagic bullous pyoderma gangrenosum following COVID-19 vaccinationY.-T. Hung,W.-H. Chung,T.-F. Tsai,C.-B. Chen
J Eur Acad Dermatol Venereol. 2022 Apr 10 doi.org/10.1111/jdv.18132

Two cases of axillary lymphadenopathy diagnosed as diffuse large B-cell lymphoma developed shortly after BNT162b2 COVID-19 vaccinationM. Mizutani,H. Mitsui,T. Amano,Y. Ogawa,N. Deguchi,S. Shimada,A. Miwa,T. Kawamura,Y. Ogido
J Eur Acad Dermatol Venereol. 2022 Apr 10 doi.org/10.1111/jdv.18136

SARS-CoV-2 mRNA booster vaccine-associated lichenoid drug eruptionD. Mintoff,D. Pisani,N. Livori,I. Said-Huntingford,G. Baldacchino
J Eur Acad Dermatol Venereol. 2022 Apr 16 doi.org/10.1111/jdv.18149

Cutaneous adverse effects of the available COVID-19 vaccines in India: a questionnaire-based studyJ. Bawane,R. Kataria,A. Mohite,K. Verma,U. Shukla
J Eur Acad Dermatol Venereol. 2022 Apr 16 doi.org/10.1111/jdv.18150

Sweet Syndrome following SARS-CoV-2 CoronaVac vaccine
N. Ben Salah,M. Korbi,N. Ben Fadhel,I. Safa,F. Chad,M. Njima,H. Belhadjali,M. Amri,K. Aouam,J. Zili
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.18336

Safe administration of subsequent mRNA COVID-19 vaccine doses following a possible allergic reaction to the first dose
M.S. Roth,S. Chantraine,C.A. Morales Mateluna,K. Hartmann,C.T. Berger
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18387

Generalized and persistent skin pigmentation after COVID-19 vaccination
J. Lu,Y. Liu,Y. Sun
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18379

Influence of Covid-19 vaccination on immune-mediated skin diseases
N. A. Alelq,M. E. Kubieniec,L. E French,J. C. Prinz
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18388

Pyoderma gangrenosum after mRNA-based SARS-CoV-2 vaccineJ. Franceschi,A.S. Darrigade,P. Sanchez-Pena,V. Legrain-Lifermann,B. Milpied
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18389

Pityriasis lichenoides chronica after BNT162b2 Pfizer-BioNTech vaccine: A novel cutaneous reaction after SARS-CoV-2 vaccine
F. Drago,G. Ciccarese,A. Guadagno,A. Parodi
J Eur Acad Dermatol Venereol. 2022 July 16 doi.org/10.1111/jdv.18418

A severe case of papulovesicular exthanthema with rhabdomyolysis after corona virus disease 2019 heterologous booster vaccination
A. Baba,Y. Maki,T. Kanekura,H. Tsubouchi
J Eur Acad Dermatol Venereol. 2022 July 16 doi.org/10.1111/jdv.18420

Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to ‘Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review’ by Pauluzzi et al.
Fabrizio Martora,Angelo Ruggiero,Teresa Battista,Gabriella Fabbrocini,Matteo Megna
J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18503

Alopecia areata after COVID-19 infection and vaccination: A cross-sectional analysis
Betty Nguyen,Antonella Tosti
J Eur Acad Dermatol Venereol. 2022 August 11 doi.org/10.1111/jdv.18491

New-onset vitiligo after COVID-19 mRNA vaccination: A causal association?
Electra Nicolaidou,Charitomeni Vavouli,Ioannis-Alexios Koumprentziotis,Maria Gerochristou,Alexander Stratigos
J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18513

Association of interstitial granulomatous dermatitis with messenger Rna–1273 Sars-Cov-2 vaccine
Cesare Ariasi,Gabriele Perazzolli,Alessandra Gelmetti,Simonetta Battocchio,Piergiacomo Calzavara-Pinton
J Eur Acad Dermatol Venereol. 2022 August 14 doi.org/10.1111/jdv.18490

New onset pemphigus foliaceus following AstraZeneca COVID-19 vaccination
Mina Almasi-Nasrabadi,Radha S. Ayyalaraju,Ashish Sharma,Somaia Elsheikh,Shanti Ayob
J Eur Acad Dermatol Venereol. 2022 August 14 doi.org/10.1111/jdv.18484

Skin reaction after SARS-CoV-2 vaccines Reply to ‘cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience’
Fabrizio Martora,Alessia Villani,Claudio Marasca,Gabriella Fabbrocini,Luca Potestio
J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18531

Reply to ‘Nail psoriasis: A rare mRNA COVID-19 vaccine reaction’ by Lamberti A et al.
Angelo Ruggiero,Luca Potestio,Teresa Battista,Gabriella Fabbrocini,Matteo Megna
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18537

Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals
Gianluca Avallone, Carlo Alberto Maronese, Claudio Conforti, Paolo Fava, Luigi Gargiulo, Angelo Valerio Marzano, Cesare Massone, Luca Mastorino, Andrea Paradisi, Alessandro Pileri, Pietro Quaglino, Nathalie Rizzo, Simone Ribero, Gabriele Roccuzzo, Gianluca Tavoletti, Carlo Alberto Vignoli, Iris Zalaudek, Emilio Berti, Silvia Alberti-Violetti
J Eur Acad Dermatol Venereol. 2022 December 05 doi.org/10.1111/jdv.18806

Epidermal necrolysis after COVID−19 vaccination: An exploratory analysis using World Health Organization VigiBase
Btisseme Ahouach, Emmanuelle Diaz, Blandine Bertin, Benoit Ben Said, Sandrine Combret, Aurélie Grandvuillemin, Nadine Petitpain, Marie Blanche Rabier, Laure Thomas, Thierry Trenque, Saskia Ingen-Housz-Oro, Bénédicte Lebrun-Vignes
J Eur Acad Dermatol Venereol. 2023 January 06 doi.org/10.1111/jdv.18845

Reply to: ‘Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab’ by Baffa et al.
L. Sun, C. Brazão, D. Mancha, L. Soares-de-Almeida, P. Filipe
J Eur Acad Dermatol Venereol. 22 January 2023 doi.org/10.1111/jdv.18893

Risk–benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study
C. Seree-aphinan, P. Suchonwanit, P. Rattanakaemakorn, C. Pomsoong, Y. Ratanapokasatit, C. Setthaudom, T. Suangtamai, K. Chanprapaph, the COVIDVAC-DERM study group
J Eur Acad Dermatol Venereol. 20 January 2023 doi.org/10.1111/jdv.18890

Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
F. Solimani, A. Mesas-Fernández, E. Bodner, M. Carevic-Neri, M. Hasheminasab, T. Jakovljevicova, A. Philipp, A. Nast, M. Worm, F. J. Hilke, K. Meier, K. Ghoreschi
J Eur Acad Dermatol Venereol. 14 February 2023 doi.org/10.1111/jdv.18967

Increasing the COVID-19 immunization rate through allergy testing
R. K. Bent, J. Weinbrenner, V. Faihs, S. Steffens, T. Nau, M. Vitus, S. Mathes, U. Darsow, T. Biedermann, K. Brockow
J Eur Acad Dermatol Venereol. 18 February 2023 doi.org/10.1111/jdv.18979

Generalized painful papulovesicular eruption following the COVID-19 BNT162b2 mRNA vaccine
J. M. Lee, Y. S. Lee, Y. J. Lee, J. H. Lee, T. Y. Han, J. E. Choi
J Eur Acad Dermatol Venereol. 13 March 2023 doi.org/10.1111/jdv.19043

Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Case Possibly Induced by COVID-19 Vaccine
Hülya Cenk, Mahmut Anıl Karataş, Niyazi Çetin, Erdem Çomut, Şule Gökşin, Özge Sevil Karstarlı Bakay, Nida Kaçar
J Eur Acad Dermatol Venereol. 28 March 2023 doi.org/10.1111/jdv.19065

Erythema multiforme major associated with molnupiravir treatment for SARS-CoV-2 infection: first report
Corrado Zengarini, Vito Epifani, Carlotta Baraldi, Martina Mussi, Luciano Potena, Laura Giovannini, Alessandro Pileri
J Eur Acad Dermatol Venereol. 05 April 2023 doi.org/10.1111/jdv.19099

VEXAS syndrome following COVID-19 mRNA vaccination
François Skowron, Lucas Klepfisch, Laurent Guillaume, Janique Godeneche, Anthony Facile, Martin Gombert, Suzann Pechuzal, Jean-Luc Perrot
J Eur Acad Dermatol Venereol. 05 April 2023 doi.org/10.1111/jdv.19104

A case of erythema elevatum diutinum after COVID-19 vaccination

Bushra Muna
J Eur Acad Dermatol Venereol. 12 May 2023 doi.org/10.1111/jdv.19188

A case of recurrence of pyoderma gangrenosum after Covid-19 vaccine

L. Bettolini, S. Bighetti, S. Mezzana, A. Gelmetti, P. Calzavara-Pinton, V. Maione

J Eur Acad Dermatol Venereol. 20 June 2023 doi.org/10.1111/jdv.19285

New-onset pemphigus vulgaris and pemphigus foliaceus following COVID-19 infection and vaccination, systematic review of case reports and a causal hypothesis

S. Petti, P. G. Arduino

J Eur Acad Dermatol Venereol. 16 June 2023 doi.org/10.1111/jdv.19271

Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS-CoV-2 vaccine – a case review

K. Kanabaj, M. Sokołowska-Wojdyło, A. Wilkowska, R. J. Nowicki

J Eur Acad Dermatol Venereol. 06 July 2023 doi.org/10.1111/jdv.19305

Ulcerating Reaction in Association with Pfizer-BioNTech COVID-19 Vaccine in an 11-Year-Old Boy

Justin Thrush, Samantha Polly, John Anthony, James Fernandez, James Taylor, DeVon C. Preston, Anthony P. Fernandez

J Eur Acad Dermatol Venereol. 23 August 2023 doi.org/10.1111/jdv.19460

A case of COVID-19-associated generalized indeterminate cell histiocytosis successfully treated with systemic PUVA

Raquel Falcão de Freitas, António Freitas

J Eur Acad Dermatol Venereol. 18 August 2023 doi.org/10.1111/jdv.19444

A case of generalized pustular psoriasis complicated by acute respiratory distress syndrome after COVID-19 vaccination

Ayaka Itami, Tomomitsu Miyagaki, Shuhei Mitsuishi, Akihiro Horie, Tatsuro Okano, Sora Takeuchi, Takayasu Ando, Takafumi Kadono

J Eur Acad Dermatol Venereol. 10 August 2023 doi.org/10.1111/jdv.19401

A severe relapse of Pemphigus Vulgaris after SARS-CoV-2 vaccination.

L. Ligrone, S. Lembo, F. Cillo, S. Spennato, G. Fabbrocini, A. Raimondo

J Eur Acad Dermatol Venereol. 10 August 2023 doi.org/10.1111/jdv.19414

Annular cutaneous sarcoidosis following COVID-19 vaccination

José Ramos, António Silva, Ângela Roda, João Alves

J Eur Acad Dermatol Venereol. 01 February 2024 doi.org/10.1111/jdv.19828

The role of COVID-19 vaccines in the development and recurrence of pemphigus and bullous pemphigoid

Gaurav N. Pathak, Anurag N. Pathak, Babar Rao

J Eur Acad Dermatol Venereol. 18 March 2024 doi.org/10.1111/jdv.19970

Occupational skin disease, including effects of PPE

Dermatology staff participate in fight against Covid-19 in ChinaZheng Y, Lai W J Eur Acad Dermatol Venereol. 2020 Mar 23. doi: 10.1111/jdv.16390Skin reactions to non-glove personal protective equipment: An emerging issue in the COVID-19 pandemicGheisari M, Araghi F, Moravvej H, Tabary M, Dadkhahfar S J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16492Covid-19: Countermeasure for N95 mask-induced pressure soreYin Z. J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16490Hand disinfection in the combat against Covid-19Goldust M, Abdelmaksoud A, Navarini AA J Eur Acad Dermatol Venereol. 2020 May 3. doi: 10.1111/jdv.16574COVID-19 epidemic: Skin protection for health care workers must not be ignoredZhang B, Zhai R, Ma L. J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16573Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patientsPei S, Xue Y, Zhao S, Alexander N, Mohamad G, Chen X, Yin M J Eur Acad Dermatol Venereol. 2020 May 3. doi: 10.1111/jdv.16570Localised mid-face miliaria as a consequence of filtering face piece (FFP) respirator use during the COVID-19 pandemicCampbell V, Middleton D, Donnelly J, Hunter H J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16624Personal protective equipment induced facial dermatoses in healthcare workers managing COVID-19 casesSingh M, Pawar M, Bothra A, Maheshwari A, Dubey V, Tiwari A, Kelati A J Eur Acad Dermatol Venereol. 2020 May 12. doi: 10.1111/jdv.16628Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease-2019: a short-term, self-controlled studyDong L, Yang L, Li Y, Yang J, An X, Yang L, Zhou N, Zhang Y, Du H, Lan J, Song Z, Miao X, Zhu J, Tao J J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16638Protecting medical staff from skin injury/disease caused by personal protective equipments during epidemic period of COVID-19: experience from ChinaH. Long, H. Zhao, Z. Yao, B. Cheng, Q. Lu J Eur Acad Dermatol Venereol 2020; May 22 doi.org/10.1111/jdv.16388Hand Eczema Pandemic Caused by COVID-19 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital PersonnelK. Greveling, A.C.M. Kunkeler J Eur Acad Dermatol Venereol 2020 June 2 doi.org/10.1111/jdv.16695Retroauricular dermatitis with vehement use of ear loop face masks during COVID‐19 pandemicBothra A, Das S, Singh M, Pawar M, Maheswari A J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16692Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United KingdomHadjieconomou S, Hughes J, Kamath S J Eur Acad Dermatol Venereol. 2020 Jun 14. doi: 10.1111/jdv.16754Symmetric chest pressure ulcers, consequence of prone position ventilation in a patient with COVID-19Martínez Campayo N, Bugallo Sanz JI, Mosquera Fajardo I J Eur Acad Dermatol Venereol. 2020 Jun 15. doi: 10.1111/jdv.16755How the use of surgical masks during COVID-19 pandemic can induce skin effectsVeronese S, Bernardi P, Sbarbati A J Eur Acad Dermatol Venereol. 2020 Sep 1. doi: 10.1111/jdv.16905Occupational dermatoses from PPE during the COVID-19 pandemic in the tropics – A reviewLee HC, Goh CL J Eur Acad Dermatol Venereol. 2020 Sep 7. doi: 10.1111/jdv.16925Adverse skin reactions following different types of mask usage during the COVID-19 pandemicC. Chaiyabutr T. Sukakul C. Pruksaeakanan J. Thumrongtharadol W. Boonchai J Eur Acad Dermatol Venereol. 2020 Nov 21 doi.org/10.1111/jdv.17039Adverse skin reactions related to PPE among health care workers managing Covid-19Priyanka Sharma Nainika Goel Kanika Dogar Mala Bhalla GP Thami Kavita Punia J Eur Acad Dermatol Venereol. 2021 Apr 18 doi.org/10.1111/jdv.17290Adverse Skin Reactions Due to Use of Face Masks: A Prospective Survey during the COVID-19 Pandemic in KoreaS.J. Park, H.S. Han, S.H. Shin, K.H. Yoo, K. Li, B.J. Kim, S.J. Seo, K.Y. Park J Eur Acad Dermatol Venereol. 2021 Jun 15 com/doi/10.1111/jdv.17447Dermatoses caused by face mask wearing during the COVID-19 pandemicO.Yu. Olisova, N.P. Teplyuk, E.V. Grekova, A.A. Lepekhova J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17546Characteristics of facial skin problems and microbiome variation during wearing masks for fighting against COVID-19C. Huang, Q. Sun, D. Jiang, X. Zhang, C. Chen, D. Yan, X. Liu, Y. Zhou, C. Ding, L. Lan, J. Wu, L. Li, A. Li, X. Liu, S. Yang J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17580Personal protective equipment use and face acne in health care providers during the COVID-19 pandemic in Romania: a new occupational acne type?S Cretu,M Dascalu,SR Georgescu,CM Salavastru J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17679Reply to “Dermatoses caused by face mask wearing during the COVID-19 pandemic”F. Bardazzi,L. Sacchelli,C. Loi,F. Filippi,A. Guglielmo J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18012Maskne prevalence and associated factors in Irish healthcare workers during the COVID-19 pandemic L.F. Kiely,C. O’Connor,G. O’Briain,C. O’Briain,J. Gallagher,J.F. Bourke J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18054Disseminated herpes zoster in an immune-competent patient after SARS-CoV-2 vaccine (BNT162b2 Comirnaty, Pfizer) C. Zengarini,C. Misciali,T. Ferrari,E. Dika,M. La Placa,B.M. Piraccini,C. Baraldi J Eur Acad Dermatol Venereol. 2022 Apr 16 doi.org/10.1111/jdv.16925

Education

Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances

Reinholz M, French LE.
J Eur Acad Dermatol Venereol. 2020 Mar 27. doi: 10.1111/jdv.16391

Dermatologic Surgery Training During the COVID-19 Era

García-Lozano JA, Cuellar-Barboza A, Garza-Rodríguez V, Vázquez-Martínez O, Ocampo-Candiani JJ Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16621

Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions

E. Welsh,J.A. Cardenas-de la Garza,E. Brussolo-Marroquín,A. Cuellar-Barboza,R. Franco-Marquez,G. Ramos-Montañez
J Eur Acad Dermatol Venereol. 2022 Apr 26 doi.org/10.1111/jdv.16391

Onset of amyopathic dermatomyositis following mRNA-based SARS-CoV-2 vaccination

A. Kreuter,S. Lausch,S.-N. Burmann,A. Paschos,A.-L. Michalowitz
J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16621

Psycho-social implications

Mass quarantine measures in the time of COVID-19 pandemic: psycho-social implications for chronic skin conditions and a call for qualitative studies

Garcovich S, Bersani FS, Chiricozzi A, De Simone C
J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16535

Role of the International Pemphigus and Pemphigoid Foundation during the COVID-19 pandemic

M. Kasperkiewicz,R. Strong,M. Yale,P. Dunn,D.T. Woodley
J Eur Acad Dermatol Venereol. 2022 Apr 25 doi.org/10.1111/jdv.16535

Impact of COVID-19 pandemic on acute dermatology referrals in a secondary and tertiary care Central London hospital. A retrospective comparison review of pre-COVID-19 era and COVID-19 pandemic

Evangelia Panagou, Evdoxia Panou, Jennifer Crawley, Ophelia Veraitch, Emma V. Edmonds, Chris B. Bunker, Claire L. Martyn-Simmons
J Eur Acad Dermatol Venereol. 24 February 2023 doi.org/10.1111/jdv.18997

The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres

Alexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, Laura Del Regno, Georg Lodde, Patrick Turko, Phil F. Cheng, Mitchell L. Levesque, Eva Hadaschik, Elisabeth Livingstone, Ketty Peris, Lukas Flatz, Peter Koelblinger, Reinhard Dummer, Florentia Dimitriou
J Eur Acad Dermatol Venereol. 14 February 2023 doi.org/10.1111/jdv.18953

Delay in the diagnosis and management of suspicious malignant skin lesions during the COVID-19 pandemic in a reference center in Mexico

Eduardo Corona-Rodarte, Antonio Olivas-Martinez, Rodrigo Solis-Pompa, Luis Enrique Cano-Aguilar, Daniel Asz-Sigall, María del Rocío Ferrusco-Ontiveros, José Alfredo Soto-Ortiz, Liliana Burgos-Mora
J Eur Acad Dermatol Venereol. 05 April 2023 doi.org/10.1111/jdv.19109

Sexual health

SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routesDelfino M, Guida M, Patrì A, Spirito L, Gallo L, Fabbrocini G
J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16591

Sexually Transmitted Infections during the COVID-19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practiceSacchelli L, Viviani F, Orioni G, Rucci P, Rosa S, Lanzoni A, Patrizi A, Gaspari V.
J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16694

STIs and the COVID-19 pandemic: the lockdown does not stop sexual infectionsBalestri R, Magnano M, Rizzoli L, Infusino SD, Urbani F, Rech G
J Eur Acad Dermatol Venereol. 2020 Jul 11. doi: 10.1111/jdv.16808

Evolution of notified sexual transmitted infections in Barcelona during the First Wave of the COVID-19 Pandemic
G. Martin-Ezquerra, P. Monreal, L. Mercuriali, E. Cañas-Ruano, R.M. Pujol, X. Duran, M. Masferrer Niubò, P. Domingo, J. Villar-Garcia, J. Lopez-Contreras, A. Gonzalez-Cordón, P. Garcia-Olalla, M.-J. Barberá, STI-HIV group of Barcelona
J Eur Acad Dermatol Venereol. 2021 Jun 19 oi/full/10.1111/jdv.17460

Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virusM. Hertel,M. Heiland,S. Nahles,M. von Laffert,C. Mura,P.E. Bourne,R. Preissner,S. Preissner
J Eur Acad Dermatol Venereol. 2022 Apr 26 doi.org/10.1111/jdv.16591

Effects of wearing personal protective equipment during COVID-19 pandemic on composition and diversity of skin bacteria and fungi of medical workersX. Lin,Y.Z. Li,T. Chen,S.H. Min,D.F. Wang,M.M. Ding,G. Jiang
J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16694

Impact of the Covid-19 pandemic on melanoma and non-melanoma skin cancer inpatient treatment in Germany – a nationwide analysisJ. Kleemann,M. Meissner,D. Özistanbullu,Ü. Balaban,O. Old,S. Kippenberger,J. Kloka,R. Kaufmann,K. Zacharowski,B. Friedrichson
J Eur Acad Dermatol Venereol. 2022 May 15 doi.org/10.1111/jdv.16808

Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIVAgit Simsek, Clara Bessen, Toni L Meister, Doris Urlaub, Adriane Skaletz-Rorowski, Norbert H Brockmeyer, Oliver Overheu, Anke Reinacher-Schick, Simon Faissner, Carsten Watzl, Stephanie Pfaender, Ingo Schmitz, Anja Potthoff, Carlos Plaza-Sirvent
J Eur Acad Dermatol Venereol. 13 March 2023 doi.org/10.1111/jdv.19036

A sharp increase in early syphilis cases in a referral hospital in Athens, Greece, 2 years into the COVID-19 pandemic

E. Nicolaidou, K. Fouseki, V. Paparizos, O. Kotsafti, V. Vasalou, E. Daskalakis, J. Lakoumentas, A. Giannoukos, G. Emmanouil, R. Kapranou, Z. Kripouri, S. Papanikou, I. Stefanaki, A. Tagka, S. Gregoriou, E. Paparizou, A. Stratigos

J Eur Acad Dermatol Venereol. 21 February 2024 doi.org/10.1111/jdv.19884

Specific diseases and patient groups

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitis

Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C
J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16411

Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic

Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT
J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16525

Skin cancer triage and management during COVID-19 pandemic

Tagliaferri L, Di Stefani A, Schinzari G, Fionda B, Rossi E, Del Regno L, Gentileschi S, Federico F, Valentini V, Tortora G, Peris K; Gemelli Skin-Cancer Multidisciplianry Tumour Board (S-MDTB)
J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16529

Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy)

Atzori L, Mugheddu C, Addis G, Sanna S, Satta R, Ferreli C, Atzori MG, Montesu MA, Rongioletti F
J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16473

Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model

Tejera-Vaquerizo A, Nagore E
J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16555

Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit

Quaglino P, Fava P, Brizio M, Marra E, Rubatto M, Agostini A, Tonella L, Ribero S, Fierro MT
J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16586

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions

Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A
J Eur Acad Dermatol Venereol. 2020 Apr 30. doi: 10.1111/jdv.16557

Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines

Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M
J Eur Acad Dermatol Venereol. 2020 May 16. doi: 10.1111/jdv.16593

Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus

Balestri R, Rech G, Girardelli CR
J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16578

COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management
Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F
J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16625

Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece

Vakirlis AE, Bakirtzi K, Papadimitriou I, Vrani F, Sideris N, Lallas A, Ioannides D, Sotiriou E
J Eur Acad Dermatol Venereol. 2020 Jun 18. doi: 10.1111/jdv.16759

Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19

Herman A, Matthews M, Mairlot M, Nobile L, Fameree L, Jacquet LM, Baeck M
J Eur Acad Dermatol Venereol. 2020 Jul 31. doi: 10.1111/jdv.16838

Severe COVID-19 outcomes in patients with psoriasis

Lima XT, Cueva MA, Lopes EM, Alora MB
J Eur Acad Dermatol Venereol. 2020 Aug 11. doi: 10.1111/jdv.16867

Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic

Martínez-Pallás I, Aldea-Manrique B, Ramírez-Lluch M, Vinuesa-Hernando JM, Ara-Martín M

J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16879

Dyrberg Loft N, Halling AS, Iversen L, Vestergaard C, Deleuran M, Rasmussen MK, Zachariae C, Thyssen JP, Skov L
J Eur Acad Dermatol Venereol. 2020 Aug 11. doi: 10.1111/jdv.16863

Delayed Melanoma diagnosis in the Covid-19 era: increased Breslow thickness in primary Melanomas seen after the Covid-19 lockdown

Ricci F, Fania L, Paradisi A, Di Lella G, Pallotta S, Sobrino L, Panebianco A, Annessi G, Abeni D.
J Eur Acad Dermatol Venereol. 2020 Aug 11. doi: 10.1111/jdv.16874

Clinical Characteristics and Outcomes in Patients With COVID-2019 and Leprosy
Santos VS, Quintans-Júnior LJ, de Souza Barboza W, Antunes de Souza Araújo A, Ricardo Martins-Filho P
J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16899

Wearing a mask and facial skin diseases: patients with atopic dermatitis express themselves
Stéphanie Merhand, Laurent Misery, Véronique Delvigne, Caroline Le Floch, Charles Taïeb
J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16917

Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic
Martínez-Pallás I, Aldea-Manrique B, Ramírez-Lluch M, Vinuesa-Hernando JM, Ara-Martín M

J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16879

Effects of lockdown on health of patients with severe atopic dermatitis treated with dupilumab
Ferrucci SM, Tavecchio S, Favale EM, Angileri L, Riva D, Romagnuolo M, Beretta AE, Marzano AV
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16955

Immunological and virological profile of children with chilblain-like lesions shows no evident link with SARS-CoV-2
L. Fertitta, A. Welfringer, A. Ouedrani, L. Polivka, S. Chhun, L. Chatenoud, J. Fourgeaud, S. Hadj‐Rabia, S. Temmam, M. Eloit, Sermet‐Gaudelus, C. Bodemer
J Eur Acad Dermatol Venereol. 2020 Oct 3. doi.org/10.1111/jdv.16972

Diagnosis of hair disorders during the COVID-19 pandemic: An introduction to teletrichoscopy
Randolph, M, Al‐alola A, Tosti A
J Eur Acad Dermatol Venereol. 2020 Oct 12. doi.org/10.1111/jdv.16989

COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data
L.E.M. de Wijs M.M. Joustra J.I. Olydam T. Nijsten D.J. Hijnen
J Eur Acad Dermatol Venereol. 2020 Nov 1 doi.org/10.1111/jdv.17025

COVID-19 and HHV8 first spotted together: an affair under electron microscopy
E. Leoni M. Cerati G. Finzi M. Lombardo F. Sessa
J Eur Acad Dermatol Venereol. 2021 18 Jan doi.org/10.1111/jdv.17123

Concerns and perceptions of patients with psoriatic disease during the COVID-19 pandemic: results from a two-wave survey by the National Psoriasis Foundation
G.C. Gondo S.J. Bell J. Slayden G. Ullmann A. Blauvelt
J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17173

Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy?
S. Piaserico P. Gisondi S. Cazzaniga G. Girolomoni P.G. Calzavara‐Pinton L. Naldi
J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17175

COVID-19 and immune checkpoint inhibitors
M.S. Ahmed H. Brehme S. Friedrich L. Reinhardt S. Blum S. Beissert F. Meier
J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17172

Rapidly progressive Alopecia Areata Totalis in a Covid-19 patient, unresponsive to Tofacitinib
S. Berbert Ferreira M.F.R. Gavazzoni Dias R. Berbert Ferreira A.C. Neves Neto R.M. Trüeb O. Lupi
J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17170

Insights into COVID-19 vaccination in patients with chronic plaque psoriasis on systemic treatments
P. Gisondi D. Geat L. Naldi S. Piaserico
J Eur Acad Dermatol Venereol. 2021 Mar 1 doi.org/10.1111/jdv.17200

COVID-19 pandemic and autoimmune bullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation
M. Kasperkiewicz M. Yale R. Strong D. Zillikens D.T. Woodley A. Recke
J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17228

Risk of severe allergic reactions to Covid-19 vaccines among patients with allergic or inflammatory skin diseases – practical recommendations. A position statement of ETFAD with external experts
J. Ring M. Worm A. Wollenberg J.P. Thyssen T. Jakob L. Klimek C. Bangert S. Barbarot T. Bieber M.S. de Bruin‐Weller P.V. Chernyshov S. Christen‐Zaech M. Cork U. Darsow C. Flohr R. Fölster‐Holst C. Gelmetti U. Gieler J. Gutermuth A. Heratizadeh D.J. Hijnen L.B. von Kobyletzki B. Kunz C. Paul L. De Raeve J. Seneschal D. Simon P.I. Spuls J.F. Stalder A. Svensson Z. Szalai A. Taieb A. Torrelo M. Trzeciak C. Vestergaard T. Werfel S. Weidinger M. Deleuran
J Eur Acad Dermatol Venereol. 2021 March 22 doi.org/10.1111/jdv.17237

Vaccination Against SARS-COV-2 and PSORIASIS: the three things every dermatologist should know
F. Diotallevi A. Campanati G. Radi E. Martina G. Rizzetto P Barbadoro M.M. D’Errico A. Offidani
J Eur Acad Dermatol Venereol. 2021 Mar 29 doi.org/10.1111/jdv.17256

Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicenter retrospective cohort study
Jorge R. Georgakopoulos Asfandyar Mufti Ron Vender Vimal H. Prajapati Jensen Yeung
J Eur Acad Dermatol Venereol. 2021 Apr 19 doi.org/10.1111/jdv.17279

Penile ischemia secondary to COVID-19: Why should the dermatologist be concerned?
P. Sarkis J. Sarkis M. Alkassis J. Assaf K. El Gharib
J Eur Acad Dermatol Venereol. 2021 Apr 18 doi.org/10.1111/jdv.17287

Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance
JM Busto‐Leis G Servera‐Negre A Mayor‐Ibarguren E Sendagorta‐Cudós M Feito‐Rodríguez A Nuño‐González MD Montero‐Vega P Herranz‐Pinto
J Eur Acad Dermatol Venereol. 2021 Apr 26 doi/abs/10.1111/jdv.17301

Adamantiades-Behçet’s disease (Behçet’s disease) and COVID-19
C.C. Zouboulis J.A.M. van Laar M. Schirmer G. Emmi F. Fortune A. Gül Y. Kirino E.‐S. Lee P.P. Sfikakis F. Shahram G.R. Wallace
J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17325

Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic
V. Piccolo, A. Bassi, G. Argenziano, C. Mazzatenta, M. Cutrone, I. Neri, R. Grimalt, T. Russo
J Eur Acad Dermatol Venereol. 2021 May 29 oi/full/10.1111/jdv.17409

Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials
D. Thaçi, D. Jullien, A. Egeberg, J.M. Carrascosa, J.J. Wu, I. Pau-Charles, P. Gisondi
J Eur Acad Dermatol Venereol. 2021 May 31 com/doi/10.1111/jdv.17427

Androgenetic alopecia in women and men is not related to COVID-19 infection severity: A prospective cohort study of hospitalized COVID-19 patients
Shatila Torabi, Mahnaz Mozdourian, Roxana Rezazadeh, Abolfazl Payandeh, Shapour Badiee, Emadodin Darchini-Maragheh
J Eur Acad Dermatol Venereol. 2021 May 12 com/doi/10.1111/jdv.17353

Patients with Primary Cutaneous Lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry
A. Sánchez-Velázquez, A. Bauer-Alonso, T. Estrach, D. Vega-Díez, P. Garcia-Muret, L. Haya, Y. Peñate, E. Acebo, R. Fernández de Misa, M. Blanes, HJ. Suh-Oh, R. Izu, E. Silva-Díaz, J. Sarriugarte, C. Román-Curto, R. Botella-Estrada, A. Mateu-Puchades, L. Prieto-Torres, V. Morillas, Me. Morillo, P. Sanchez-Caminero, L. Calzado, A. Pérez-Ferriols, A. Pérez, JD. Domínguez, M. Navedo, C. Muniesa, A. Combalia, J. Arroyo-Andrés, MA. Descalzo, I. García-Doval, PL. Ortiz-Romero
J Eur Acad Dermatol Venereol. 2021 Jun 1 com/doi/10.1111/jdv.17430

A review of nail findings associated with COVID-19 infection
Edward Hadeler, Brian W. Morrison, Antonella Tosti
J Eur Acad Dermatol Venereol. 2021 Jun 15 com/doi/10.1111/jdv.17448

The Significance of Exanthems in COVID-19 Patients Hospitalized at a Tertiary Care Center
R. Rrapi, S. Chand, J.A. Lo, C.K. Gabel, S. Song, Z. Holcomb, C. Iriarte, K. Moore, C.R. Shi, H. Song, F.D. Xia, D. Yanes, R. Gandhi, V.A. Triant, D. Kroshinsky
J Eur Acad Dermatol Venereol. 2021 Jun 19 com/doi/10.1111/jdv.17459

Ulcus vulvae acutum and SARS-Co V-2: an etiological role?
M.C. Alberelli, A. Panariello, M. Olivi, A. Borghi, P. Zedde, M. Corazza
J Eur Acad Dermatol Venereol. 2021 Jun 21 oi/10.1111/jdv.17463?af=R

Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study
Erica Koch, Francisco Villanueva, Michael A. Marchetti, Álvaro Abarzúa-Araya, Consuelo Cárdenas, Juan Camilo Castro, Francisco Dominguez, Katherine Droppelmann, Nicolás Droppelmann, Héctor Galindo, Augusto León, Jorge Madrid, Montserrat Molgó, Sebastián Mondaca, Pablo H. Montero, Pablo Uribe, Miguel A. Villaseca, Eugenio Vinés, Cristian Navarrete-Dechent
J Eur Acad Dermatol Venereol. 2021 Jul 14 oi/full/10.1111/jdv.17522

Impact of the COVID-19 pandemic on melanoma diagnosis
P. Gisondi, S. Cazzaniga, S. Di Leo, S. Piaserico, F. Bellinato, M. Pizzolato, A. Gatti, A. Eccher, M. Brunelli, D. Saraggi, G. Girolomoni, L. Naldi
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17493

The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activities
Clio Dessinioti, Claus Garbe, Alexander J Stratigos
J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17552

COVID-19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria
P.R. Criado,M. Ianhez,C.C. Silva de Castro,C. Talhari,P.M. Ramos,H.A. Miot
J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17635

Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study
Y. Lytvyn,J.R. Georgakopoulos,A. Mufti,A.R. Devani,M.J. Gooderham,V. Jain,P. Lansang,R. Vender,V.H. Prajapati,J. Yeung
J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17749

Impact of the French COVID-19 pandemic lockdown on new melanoma diagnosis delay and severity
R. Molinier,A. Roger,B. Genet,A. Blom,C. Longvert,L. Chaplain,M. Fort,P. Saiag,E. Funck-Brentano
jdv.17802

Immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs
A. Cristaudo,D. Graceffa,F. Pimpinelli,F. Sperati,G. Spoletini,C. Bonifati,R. Pellini,V. Lora,M. Pontone,O. Di Bella,D. Bracco,A. Morrone
J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17861

Lack of association between seborrheic dermatitis and SARS-CoV-2 outcomes
U. Rakita,T. Kaundinya,A. Guraya,K. Nelson,B. Maner,J. Manjunath,G. Schwartzman,B. Lane,J.I. Silverberg
J Eur Acad Dermatol Venereol. 2021 Nov 22 doi.org/10.1111/jdv.17825

Concomitant SARS-CoV-2 infection and crusted scabies in a 4-month infant
A. Giannattasio,M. Rosa,S. Esposito,O. Di Mita,F. Angrisani,S. Acierno,C. D’Anna,F. Barbato,V. Tipo,O. Ametrano
J Eur Acad Dermatol Venereol. 2021 Dec 4 doi.org/10.1111/jdv.17850

Primitive Melanoma and Covid 19 are we still paying the price of the pandemic?
F. Ricci,G. Di Lella,L. Fania,F. Ricci,L. Sobrino,S. Pallotta,A. Panebianco,C. Fortes,D. Abeni
J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17892

High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with SARS-CoV-2 infection
B. Mille,S. Ingen-Housz-Oro,N. De Prost,G. Voiriot,A. Soria,F. Tetart,C. Bernier,C. Morice,D. Staumont-Salle,F. Dezoteux,(“French Investigator for Skin Adverse Reaction to Drugs”)
J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17885

The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: trends in diagnoses and magnitude of diagnostic delays
E. Slotman,K. Schreuder,T.E.C. Nijsten,M. Wakkee,L. Hollestein,A. Mooyaart,S. Siesling,M.W.J. Louwman
J Eur Acad Dermatol Venereol. 2022 Jan 28 doi.org/10.1111/jdv.17976

Clinical improvement of atopic dermatitis in two patients co-affected with non-severe COVID-19 infection: A case series and review of literature
G. Licata,D. Buononato,C. Fiorentino,G. Calabrese,A. De Rosa,G. Argenziano,A. Gambardella
J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17913

Atopic Dermatitis exacerbation after Covid-19 vaccination in Dupilumab treated patients
L. Potestio,M. Napolitano,L. Bennardo,G. Fabbrocini,C. Patruno
J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17964

Primary cutaneous lymphoma and risk for severe COVID-19: a prospective study of 48 cases in Morocco
H. Kerrouch,M. Khalidi,R. Frikh,N. Hjira,M. Boui
J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18057

Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience
L. Stingeni,L. Bianchi,E. Antonelli,E.S. Caroppo,S.M. Ferrucci,M. Ortoncelli,G. Fabbrocini,E. Nettis,D. Schena,M. Napolitano,M. Gola,L. Bonzano,M. Rossi,A. Belloni Fortina,A. Balato,K. Peris,C. Foti,F. Guarneri,M. Romanelli,C. Patruno,P. Savoia,M.C. Fargnoli,F. Russo,E. Errichetti,T. Bianchelli,L. Bianchi,G. Pellacani,C. Feliciani,A. Offidani,M. Corazza,G. Micali,N. Milanesi,G. Malara,A. Chiricozzi,M. Tramontana,K. Hansel,DADA – Dupilumab for Atopic Dermatitis of the Adolescence Study Group
J Eur Acad Dermatol Venereol. 2022 Apr 12 doi.org/10.1111/jdv.18141

Impact of containment and social distancing on the number of community-acquired Staphylococcus aureus skin infections
P. Del Giudice,J. Gillon,L. Roudiere,M. Reverte
J Eur Acad Dermatol Venereol. 2022 Mar 29 doi.org/10.1111/jdv.18111

Healthcare and safety of patients with melanoma during the COVID-19 Pandemic in Italy
S. Caini,M. Brusasco,G. Niero,V. De Giorgi,M. Lombardo,C. Massone,M. Medri,G. Palmieri,M.A. Pizzichetta,P. Quaglino,R. Satta,C. Feliciani,S. Gandini,I. Stanganelli,Italian Melanoma Intergroup (IMI), Italian Association of Melanoma Patients (AIMaMe)
J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18056

Non-allergic nature of vast majority of cutaneous adverse reactions to mRNA COVID-19 vaccines: implications on treatment and re-vaccination
T. Ju,S.Y.D. Lim,G. Yosipovitch,H.L. Tey
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16989

Long-term effects of the COVID-19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics
G. Balakirski,A.-L. Michalowitz,A. Kreuter,S.C. Hofmann
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16972

Association between COVID-19 vaccination and autoimmune bullous diseases: a random coincidence or rare event
Michael Kasperkiewicz
J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16411

A case of onychomadesis associated with chilblain-like lesions after COVID-19 infection
C. Colonna,S. Giacalone,M. Zussino,N.A. Monzani,S. Cambiaghi,R. Cavalli
J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16525

Reactive infectious mucocutaneous eruption triggered by COVID-19 infection in an adult patient
E. Gimeno,D. Morgado-Carrasco,D. Moriscot,J. Piquero-Casals
J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16529

Erythrodermic pityriasis rubra pilaris after SARS-CoV-2 vaccination with concomitant COVID-19 infection
T. Gambichler,C.H. Scheel,Y. Arafat,O. Kautz,S. Boms
J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16473

Allergic reaction to red cosmetic lip tattoo with possible exacerbations after SARS-CoV-2 vaccination
N. Kluger
J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16555

Development of delayed dermal hypersensitivity reaction following the second dose of COVID-19 vaccine – A series of 37 cases
A. Mohta,M. K. Sharma
J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16586

Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis
C. Washrawirul,J. Triwatcharikorn,J. Phannajit,M. Ullman,P. Susantitaphong,P. Rerknimitr
J Eur Acad Dermatol Venereol. 2022 June 06 doi.org/10.1111/jdv.16557

Generalized morphea after COVID-19 vaccines: a case series
G. Paolino,C. Campochiaro,M.R. Di Nicola,S.R. Mercuri,N. Rizzo,L. Dagna,F. Rongioletti,G. De Luca
J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16593

Complete remission of primary cutaneous follicle centre cell lymphoma associated with COVID-19 vaccine
S. Aouali,M. Benkaraache,Y. Almheirat,N. Zizi,S. Dikhaye
J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16578

Maskne prevalence and risk factors during the COVID-19 pandemic
A. Villani,G. Fabbrocini,M.C. Annunziata,L. Potestio
J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16625

Efficacy of low-dose methotrexate in a short-regimen for granulomatous sarcoid-like reaction on permanent make-up during COVID-19 infection

N. Kluger,V. Descamps

J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16625

Nail psoriasis: a rare mRNA COVID-19 vaccine reaction
A. Lamberti,V. Lora,D. Graceffa,C. Bonifati,C. Cota
J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16759

A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford–AstraZeneca COVID-19 vaccine
F. Filippi,C. Baraldi,P.L. Zinzani,B. Casadei,A. Pileri
J Eur Acad Dermatol Venereol. 2022 May 26 doi.org/10.1111/jdv.16838

Urticarial vasculitis triggered by SARS-CoV-2 vaccine (mRNA vaccine)
M. Daldoul,M. Korbi,A. Bellalah,N. Ben Fadhel,H. Belhadjali,J. Zili
J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16867

Hansen’s disease case detection in Brazil: a backlog of undiagnosed cases due to COVID-19 pandemic
P. Deps,S.M. Collin,V.L.G. de Andrade
J Eur Acad Dermatol Venereol. 2022 June 09 doi.org/10.1111/jdv.16879

New onset of sarcoidosis after COVID-19 infection
A. Rabufetti,L. Borradori,K. Heidemeyer,L. Feldmeyer,R.E. Hunger,N. Yawalkar,S.M. Seyed Jafari
J Eur Acad Dermatol Venereol. 2022 June 10 doi.org/10.1111/jdv.16863

Reply to ‘Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2’ by Solimani et al
F. Martora,G. Fabbrocini,P. Nappa,M. Megna
J Eur Acad Dermatol Venereol. 2022 June 09 doi.org/10.1111/jdv.16874

Erythema nodosum following SARS-CoV-2 vaccine
Y. Xie,B. Yin,X. Shi
J Eur Acad Dermatol Venereol. 2022 June 09 doi.org/10.1111/jdv.16899

Types and prevalence of adverse skin reactions associated with prolonged N95 and simple mask usage during the COVID-19 pandemic
A.R. Darnall,D. Sall,C. Bay
J Eur Acad Dermatol Venereol. 2022 June 24 doi.org/10.1111/jdv.16917

Hand–foot syndrome like eruption following mRNA COVID-19 vaccine
M. Daldoul,M. Korbi,N. Ben Salah,A. Bellalah,H. Belhadjali,J. Zili

J Eur Acad Dermatol Venereol. 2022 June 28 doi.org/10.1111/jdv.16879

Scabies revisited in the COVID-19 era
I. Trave,A. Muracchioli,E. Cozzani,A. Parodi
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16955

Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry)
J. Zitouni,A.-C. Bursztejn,A. Belloni Fortina,A. Beauchet,V. Di Lernia,A. Lesiak,J. Thomas,Z. Topkarci,N. Murashkin,P. Brzezinski,T. Torres,A. Chiriac,C. Luca,T. McPherson,M. Akinde,A. Maruani,R. Epishev,H. Vidaurri de la Cruz,P.C. Luna,M. Amy de la Bretêque,A. Lasek,E. Bourrat,M. Bachelerie,S. Mallet,M. Steff,A. Bellissen,I. Neri,E. Zafiriou,J.M.P.A. van den Reek,E. Sonkoly,S.K. Mahil,C.H. Smith,C. Flohr,H. Bachelez,E. Mahé,the Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, the Groupe de recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), the PsoProtect study group, the British Society of Paediatric Dermatology (BPSD), and the Società Italiana di Dermatologia Pediatrica (S.I.Der.P.)
J Eur Acad Dermatol Venereol. 2022 June 24 doi.org/10.1111/jdv.18361

Reactions in leprosy patients triggered by COVID-19 vaccination – a cross-sectional study from a tertiary care centre in India
A. Bhandari,Shilpa,S. Gupta,S. Dogra,T. Narang
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18390

Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic

Maria Jose Monroy-Iglesias,Hajer Hadi,Beth Russell,Charlotte Moss,Lucy Flanders,Saoirse Dolly,Sophie Papa,Mieke Van Hemelrijck
J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18514

Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation

Michael Kasperkiewicz,Rebecca Strong,Marc Yale,Patrick Dunn,David T. Woodley
J Eur Acad Dermatol Venereol. 2022 August 14 doi.org/10.1111/jdv.18493

Reply to ‘Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al.

Angelo Ruggiero,Fabrizio Martora,Fabrizio Fornaro,Massimiliano Scalvenzi,Gabriella Fabbrocini,Alessia Villani
J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18512

Reply to A. Ruggiero et al. to our article ‘Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity’

Rafaele Molinier,Anissa Roger,Bastien Genet,Philippe Saiag,Elisa Funck-Brentano
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18542

Rituximab in immunobullous disorders during the COVID-19 pandemic: A systematic review of observational studies

Michael Kasperkiewicz, David T. Woodley
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18538

Seroconversion and neutralizing antibodies production after completion of Pfizer-BioNTech BNT 162b2 vaccination scheme among psoriatic patients receiving biological or topical treatment: A prospective observational cohort study

Giuseppe Stinco, Enzo Errichetti, Matteo Figini, Alba Guglielmo, Benedetta Fazzi, Luca Quartuccio, Alen Zabotti, Salvatore De Vita, Miriam Isola, Maria De Martino, Silvia Rossi, Riccardo Lucis, Martina Fabris, Antonio Paolo Beltrami, Francesco Curcio, Federica D’Aurizio
J Eur Acad Dermatol Venereol. 2022 December 07 doi.org/10.1111/jdv.18809

Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy
Jan-Malte Placke, Delphine Mertens, Alpaslan Tasdogan, Eleftheria Chorti, Dirk Schadendorf, Selma Ugurel, Alexander Roesch, Ingo Stoffels, Joachim Klode
J Eur Acad Dermatol Venereol. 2023 January 06 doi.org/10.1111/jdv.18847

Interplay between Adamantiades-Behçet’s disease and COVID-19 – a case series from the German registry of Adamantiades-Behçet’s disease
Anthony Lim, Andreas Altenburg, Christos C. Zouboulis
J Eur Acad Dermatol Venereol. 03 February 2023 doi.org/10.1111/jdv.18939

Heterologous versus homologous primary and booster COVID-19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real-life, multicenter, case–control study
Santo Raffaele Mercuri, Alessia Pacifico, Piergiorgio Malagoli, Vittoria Giulia Bianchi, Fabrizio Ernesto Pregliasco, Massimo Del Fabbro, Giovanni Damiani
J Eur Acad Dermatol Venereol. 03 February 2023 doi.org/10.1111/jdv.18943

Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination
Thilo Gambichler
J Eur Acad Dermatol Venereol. 13 March 2023 doi.org/10.1111/jdv.19046

SARS-CoV-2 vaccination status and adverse events among patients with psoriasis—Data from the German Registries PsoBest and CoronaBest
María José Valencia López, Anna Meineke, Brigitte Stephan, Stephan Jeff Rustenbach, Anne Kis, Diamant Thaçi, Ulrich Mrowietz, Kristian Reich, Petra Staubach-Renz, Ralph von Kiedrowski, Henriette Bogena, Matthias Augustin
J Eur Acad Dermatol Venereol. 13 March 2023 doi.org/10.1111/jdv.19039

Increased risk of COVID-19-related hospitalization in patients with hidradenitis suppurativa
Jonathan Koptyev, Andrew Strunk, Amit Garg

J Eur Acad Dermatol Venereol. 13 March 2023 doi.org/10.1111/jdv.19033

Impact of COVID-19 in patients with autoimmune bullous diseases: report from an international registry

Joost M. Meijer, Hanan Rashid, Styliani Vergadi, Emiliano Antiga, Pamela Vezzoli, Riccardo Balestri, Aikaterini Patsatsi, Soner Uzun, Dusan Skiljevic, Hana Jedlickova, Lucia Janickova, Alberto Corrà, Alessandra Ponziani, Claudia Günther, Giuseppe Cianchini, Matthias Schefzyk, Angelo Marzano, Giovanni Di Zenzo, Iakov Shimanovich, Janet Fairley, Jose M. Mascaró Jr, Marzia Caproni, Roberto Maglie, Enno Schmidt, Barbara Horváth

J Eur Acad Dermatol Venereol. 08 June 2023 doi.org/10.1111/jdv.19242

Gianotti-Crosti syndrome following Covid-19 infection

M. Ben Kahla, J. Rouatbi, N. Ghariani Fetoui, A. Aounallah, B. Sriha, C. Belajouza, N. Ghariani, S. Mokni, M. Lahouel, M. Denguezli

J Eur Acad Dermatol Venereol. 17 July 2023 doi.org/10.1111/jdv.19343

The Gabrin Sign’s Potential for Identifying High-Risk Patients for COVID-19 with Androgenic Alopecia

Alpana Mohta, Sumiti Pareek, Vijeta Prasad, Achala Mohta, Asha Nyati

J Eur Acad Dermatol Venereol. 14 Sep 2023 doi.org/10.1111/jdv.19514

Cutaneous Tuberculosis and its possible association with COVID-19

Neerja Saraswat, Durga Madhab Tripathy, Abhishek Mishra, Sushil Kumar, Shobhit Goel

J Eur Acad Dermatol Venereol. 31 Oct 2023
doi.org/10.1111/jdv.19592

Attitudes towards clinical research in adult patients with hidradenitis suppurativa during the COVID-19 pandemic: insights from a survey

Nikolaj Holgersen, Valdemar W. Nielsen, Zarqa Ali, Mette Brøgger-Mikkelsen, Marius M. Flege, Jacob P. Thyssen, Alexander Egeberg, Simon F. Thomsen

J Eur Acad Dermatol Venereol. 18 December 2023 doi.org/10.1111/jdv.19758

The impact of COVID-19 pandemic on the number of first diagnosis and follow-up visits of patients affected by pemphigus, bullous pemphigoid, scleroderma, psoriasis and vitiligo: A single center experience

Francesco Moro, Feliciana Mariotti, Anna Pira, Luciano Sobrino, Sabatino Pallotta, Annarita Panebianco, Giovanni Di Zenzo

J Eur Acad Dermatol Venereol. 24 February 2024 doi.org/10.1111/jdv.19885

Flares and new related lesions of Hidradenitis Suppurativa following COVID-19 vaccination: A retrospective cohort study of 250 patients in Greece

Aikaterini I. Liakou, Andreas G. Tsantes, Magdalini Kalamata, Lydia Tsamtsouri, Efthymia Agiasofitou, Soultana Vladeni, Angeliki Dragoutsou, Evangelia-Konstantina Bompou, Konstantina A. Tsante, Eleni Chatzidimitriou, Ourania Kotsafti, Stefanos Bonovas, Alexandros I. Stratigos

J Eur Acad Dermatol Venereol. 21 March 2024 doi.org/10.1111/jdv.19968

Teledermatology

Skin cancer and COVID-19: was the diagnosis safeguarded by teledermatology? a study on 1229 cases

C. Skayem,C. Hua,O. Zehou,A. Jannic, A. Viarnaud,P. Wolkenstein,T.A. Duong
J Eur Acad Dermatol Venereol. 2022 Apr 20 doi.org/10.1111/jdv.16905

Impact of SARS-CoV-2 infection in children with psoriasis: Results of a monocentric experience

Francesca Caroppo, Laura Fagotto, Jacopo Tartaglia, Roberto Mazzetto, Anna Belloni Fortina
J Eur Acad Dermatol Venereol. 17 January 2023 doi.org/10.1111/jdv.18874

Covid 19 Articles

COVID-19 Articles

Cross-country comparisons of Google searches for chilblains before and during the COVID-19 pandemic

Cross-country comparisons of Google searches for chilblains before and during the COVID-19 pandemic

Further Reading